Bravida wins large installation contract when Uppsala University Hospital expands

Uppsala University Hospital, Akademiska sjukhuset, is about to be modernized. In the years leading up to 2023, the hospital will be equipped with both entirely new and renovated premises. Among other things, there will be an entirely new patient care building. Skanska has entrusted Bravida with all heating and plumbing installations in the new building. Sven Andersson, installation sourcing manager at Skanska, is pleased with the choice: – For Skanska, this is a project of considerable size, and the choice of supplier is largely a matter of trust. Bravida is a large company, and they have several similar projects in their track record. We can see that they have the capability of carrying out a project of this magnitude, he says. Bravida’s installations will include solutions for waste water, roof drainage, tap water, heating and cooling, among other things. The project started in the beginning of August and includes about 50 000 square metres of new hospital premises. The building will cointain 96 single patient rooms, 10 operating rooms, and a new medical health centre with a large number of consulting rooms, day care rooms and dialysis spots. There will also be an auditorium with a capacity for 130 people. – It’s great that Bravida has been entrusted with yet another hospital assignment. It points to our competencies in the area. This project will further deepen our cooperation with Skanska. At the same time, it enables our employees to further develop their skills in this type of installations, says Tomas Ekberg, Branch Manager at Bravida Heating and Plumbing in Uppsala. The project, which has a target order value of SEK 110 million, is estimated to be completed in August 2018. For further information, please contact:Tomas Ekberg, Branch Manager, Bravida Heating and Plumbing, Uppsala.Phone: +46 18-65 00 15Johan Brodin, Branch Manager, Bravida Region Uppland .Phone: +46 18-65 00 00

First certified app to tackle skin cancer in the UK

SkinVision has launched the first certified skin cancer risk analysis app offering a tool for analysing moles and other skin conditions for the three most common types of skin cancer: melanoma, basal cell carcinoma and squamous cell carcinoma. The simple and effective app is an at-hand solution for self monitoring. And it’s already saving lives. Most common cancer in the UK Skin cancer is now the most common cancer in the UK and for many it can prove fatal. Every year 2,500 people die due to skin cancer, that’s seven people every day. Incidents of melanoma, the most deadly form of skin cancer, is also rising. Since the 1970’s melanoma has quadrupled amongst women and increased sevenfold in men. How the SkinVision app works The app is the first in the world to use a mathematical formula incorporating fractal geometry in risk analysis. The app’s algorithm calculates the fractal dimension of skin lesions to build a structural map that reveals the different growth patterns of the tissues, providing an instant online risk assessment. Supportive tool for GP checks The SkinVision app has an 88% sensitivity score to detect melanoma skin cancer. That makes the app a supportive tool for traditional GP check-ups, to improve the accuracy of those checks. It’s an example of how digital tools are changing and supporting the healthcare system in the UK. SkinVision CEO Dick Uyttewaal said: “We’re pleased that SkinVision is available in the UK where we can really work with individuals and the healthcare system to raise awareness about the importance of skin cancer checks. The SkinVision application provides ever-improving technology to regularly track moles for changes and enable timely visits to a doctor. In the UK, a country with rising skin cancer rates, awareness of one’s own skin has never been more important.” Real-life use cases Caroline Salmon says the app saved her life. The Cambridgeshire 49-year-old, who is mum to Beatrice, 18, and William, 16, says: “I have always had fair skin but love being in the outdoors. Then in 2015, I noticed that what seemed to be an innocent freckle on my right leg, had begun to subtly change size and shape. Having worked as a health care professional for most of my life, I had seen many pictures of what to look out for with regard to melanomas. “Then I came across the SkinVision app on Facebook. After taking a photograph and analysing the freckle I saw the reply was “High risk”. As soon as possible, I made an appointment to see my GP who told me that I was the third person to use the app. Pretty quickly, I was sent off to the hospital at Addenbrookes Cambridge Hospital, to have the freckle removed. After 2 weeks of recovery I was desperate to know if the freckle was a melanoma. Four weeks later I received my results over the phone - I did have a melanoma. “My leg is healing nicely now, but if it hadn’t been for SkinVision then I would never have thought twice about that freckle. I’m grateful the app gave me the push I needed to see my GP.” SkinVision is available for both iOS and Android Samsung users. People in the UK can download the SkinVision app with a one-month free trial: https://skinvision.com

Welsh travel experts extend sponsorship of rugby giants

After Wales’ success in the European Football Tournament, the country is set to be gripped by their first sport as the Welsh Rugby season kicks off in September. And one company who can’t wait for the new season is holiday experts, Leisuretime. The leading provider of premier coach trips to the UK, Europe beyond, has extended its sponsorship of Merthyr RFC, one of the biggest clubs in Wales, and will be the title sponsor for the upcoming season, after previously partnering with the club over the last two years. Further cementing their long-standing relationship with the sporting team, the company is set to adorn the team’s shirts and work with them throughout the coming year. George Johnson, Director, said, “We are ecstatic to be extending our partnership with the team for the second year running. Rugby really is part of daily life for many here in Wales, and as one of the most successful businesses in south Wales, we are committed to giving back and supporting the community in South Wales and beyond.” Owned by Welsh businessman and property developer, Sir Stanley Thomas, Merthyr RFC had an incredible season last year. Finishing top of the WRU Championship, the team is now set to play in the Principality Premiership for the coming season. In order to get ready for their premier challenge, the team has lead the way and had a 4g pitch installed at their home, The Wern Sports Park. One of the first Welsh Rugby clubs to take the leap towards an artificial field, the players are ready and raring to go and tackle some of the finest teams in the world, including Newport, Cardiff and Ebbw Vale, and set to be thrust onto one of the biggest stages in rugby. Chanelle Murphy, Holiday Sales Consultant said “Our Coach Holiday Shop is located close to the Merthyr RFC ground in Merthyr town centre, so we can’t wait for the new season to kick off and hear the thousands of fans cheering on their local heroes.” To find out more about Leisuretime and the fantastic destinations they run holidays to, visit the website: www.leisuretime.co.uk. Keep up to date on social media: Facebook: https://www.facebook.com/leisuretimeuk Twitter: https://twitter.com/LeisuretimeUK

AcadeMedia publishes the Nomination Committee for the AGM in 2016

The Nomination Committee, which is appointed in accordance with the principles adopted by the Annual General Meeting December 18, 2015, consists of: · Erika Henriksson *, Marvin Holding Limited · Rune Andersson, Mellby Gård · Johan Lannebo, Lannebo Fonder · Ulf Mattsson * (Chairman of the Board) Chairman of the Nomination Committee is Rune Andersson. The Board of AcadeMedia AB (publ) ____________________________ For further information, seehttps://corporate.academedia.se/en/corporate-governance/nomination-committee/ Shareholders who wish to submit proposals to the Nomination Committee for the Annual General Meeting November 17, 2016 may do so by sending an e-mail to valberedning@academedia.se. Proposals shall, in order to be taken into consideration by the Committee, be submitted by 29 September, 2016. For more information, please contact:Christian Hall, Investor RelationsTelephone: 0763-111 242E-mail: christian.hall@academedia.se About AcadeMediaAcadeMedia is the leading and single largest independent education provider in northern Europe. In 2014/15, approximately 62 000 children and students attended AcadeMedia’s preschools, compulsory schools and upper secondary schools. An additional 80 000 individuals participated in AcadeMedia’s adult education courses. In 2014/15, AcadeMedia had approximately 400 preschools, compulsory schools and upper secondary schools in Sweden and Norway and approximately 150 adult education units in Sweden. In February 2016, AcadeMedia also took a first step in the Company’s expansion outside Scandinavia through the acquisition of Joki, which operates seven preschools with approximately 450 children in the Munich region of Germany. AcadeMedia has operations throughout the education chain, from preschool, compulsory school and upper secondary school to adult education. More information about AcadeMedia is available on www.academedia.se This information is information that AcadeMedia AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on August 22 2016. * If more than one member of the Board is included in the nomination committee, only one of them should be dependent in relation to the major shareholders, according to the Swedish Corporate Governance Code. AcadeMedia has nevertheless selected Erika Henriksson and Ulf Mattsson to be part of the Nomination Committee.

Cherry-owned Game Lounge expands into Germany and UK through acquisition

In addition to incremental earnings, the acquisition will further strengthen Game Lounge’s position within the affiliate segment and take the step into the large German and UK markets, which are currently growing rapidly.The acquisition is fully financed through cash by Game Lounge operations and is expected to increase revenue with approximately €1,3m and EBITDA figures by more than €1m annually. The deal is expected to generate ROI in less than eighteen months. The acquisition will be integrated into Game Lounge’s existing operations and create new external affiliate-income and also support the Cherry brands.   Jonas Cederholm, CEO of Game Lounge, commented: “We are very happy to have reached an agreement with Interclick Limited, a company that has a long experience of affiliation. Both the German and UK markets are large and growing rapidly. The acquisition of the Interclick assets further accelerates our strategy and expansion beyond Scandinavia, and will be a beneficial contribution from day one.”   Fredrik Burvall, CEO of Cherry, commented: "The acquisition of the domains puts Cherry and Game Lounge in a stronger position in the affiliate sector, especially within the German and UK markets. We have been very pleased with the performance of Game Lounge so far, and this acquisition is very much in line with Cherry’s expansion plans. The affiliate market is an important part of the online gaming industry and Cherry continues to strengthen its online business with this acquisition.” For further information, please contact:Jonas Cederholm, CEO of Game Lounge Ltd, Telephone +356 991-70 863 jonas@gamelounge.com Fredrik Burvall, CEO of Cherry AB (publ), Telephone +46 8-514 969 52, +46 709-279 632, fredrik.burvall@cherry.se Cherry in brief  Cherry is a Swedish gaming company established in 1963 specialized in online casinos and lotteries (www.CherryCasino.com, www.EuroLotto.com, www.EuroSlots.com, www.SpilleAutomater.com, www.SveaCasino.com, www. SuomiAutomaatti.com, www.NordicSlots.com, www.NorgesSpill.com, www.ComeOn.com, www.Mobilbet.com, www.Casinostugan.com, www.folkeautomaten.com www.Suomikasino.com, www.GetLucky.com and www.Kasyno.pl), affiliate business through Game Lounge and games development (www.Yggdrasil.com), through subsidiaries in Malta. Cherry is the market leader in casinos in restaurants and nightclubs in Sweden. Cherry employs around 750 people and has more than 3,800 shareholders. The Company's B-shares are listed on AktieTorget.   

ESS Data Management and Software Centre Opens in Copenhagen

The research facility European Spallation Source (https://europeanspallationsource.se) (ESS) celebrates on August 26 the opening of the ESS Data Management and Software Centre (DMSC) permanent offices in Copenhagen. The Danish Minister for Higher Education and Science, Ulla Tørnæs, the Prorector for Research and Innovation at the University of Copenhagen, Thomas Bjørnholm, and the ESS Director for Science, Andreas Schreyer, will speak at the ceremony. Representatives from the Capital Region of Denmark, Confederation of Danish Industry (DI) and Danish ESS Partner Universities and Laboratories, such as DTU and Niels Bohr Institute, will among others attend the event. The Data Management and Software Centre (DMSC) in Copenhagen is a vital part of the European Spallation Source, currently under construction in Lund. DMSC will store and process the experimental data that will be generated at ESS. The DMSC staff is now developing software and hardware for the control, analysis, and visualization of the experiments to be carried out at ESS, in collaboration with partners at universities and research laboratories all over Europe. When ESS is in full operations, by 2025, DMSC will have 60-70 employees, mainly in Copenhagen. During the ceremony the official DMSC Door plate will be handed over to Mark Hagen, Head of DMSC. We cordially invite members of the media to attend the event and the following reception. Place: DMSC, COBIS, Ole Maaløes Vej 3, Copenhagen (https://europeanspallationsource.se/page/directions-dmsc-copenhagen), Date: August 26 Time:    10:15 Presentation DMSC and ESS for media - Mark Hagen, Head of DMSC             11:00 Messages of Congratulation             11:30 Hand-over of the DMSC Door Plate             11:40 1:1 media interviews             12:00 Reception

Leading online estate agent launches new website to give control back to homeowners

The UK’s leading online estate agent, I Am The Agent has shaken up what it means to sell or let a home online with a totally new look website which went live this week. The reinvigorated iamtheagent.com is a vibrant portal for homeowners, landlords, buyers and tenants, built on more than five years’ research and fuelled by feedback from 70,000 registered users. The new website has been carefully crafted to simplify the process of buying and selling a property. Bridging the gap between homeowners and their prospective buyers or tenants, expect powerful new features including the ability to highlight the best bits of a house or flat and 24/7 access to update selling points in the cloud, on the go and at home. Rebecca Peach, managing director of I Am The Agent, said, “Our vision is to make selling and renting a home simpler, clearer and cheaper with a professional, yet personal service that buyers and sellers alike can trust. We’ve worked with an expert team of web designers, marketers, property professionals and usability experts to take Iamtheagent.com to new heights. It’s intuitive, functional and adaptive, packed with useful tools, equipped with full access to some of the biggest property portals in the world and backed by an in-house team of estate agents.” The new online portal provides users with a unique platform to creatively showcase their property. It follows the I Am The Agent ethos of ‘I Am Saving. I Am In Control. I Am The Agent’, and gives back control to homeowners so they can market their property as they see fit. I Am The Agent operates a no hidden costs or charges policy. Its completely transparent service encompasses a number of options for sales and lettings, with a range of packages and support levels to suit all budgets and selling or letting experience. It is committed to going above and beyond what other online-only estate agents offer. Advertising timescales are generous, with a year allowed for sales and up to six months for lettings. The estate agent also offers assisted viewings as an optional extra. The most popular sales package comes with free pro photos and floor plan or an EPC. Clients signing up to Iamtheagent.com are assigned a dedicated property assistant who will guide the user through the process from start to finish, as well as arrange assisted viewings if required. Prices start at £19 to let, and £49 to sell. This makes them significantly cheaper than the industry average of £597, while giving users something extra – full control at the touch of a button. To find out more visit: http://www.iamtheagent.com

Citycon Oyj: Managers’ Transactions

Person subject to the notification requirement: Arnold de Haan, Member of the Board of DirectorsIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification reference number: 549300P8N0P6KDGTJ206_20160819180003_3 1) TransactionsDate: 18 August 2016Venue: CHIXInstrument type: share, CTY1S  ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 127, unit price: 2.27000 EUR(2) volume: 232, unit price: 2.27000 EURAggregated transactionsTotal volume: 359Volume weighted average price: 2.27000 EUR 2) TransactionsDate: 18 August 2016Venue: TRQXInstrument type: share, CTY1S ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 766, unit price: 2.27000 EURAggregated transactionsTotal volume: 766Volume weighted average price: 2.27000 EUR 3) TransactionsDate: 18 August 2016Venue: BATEInstrument type: share, CTY1S ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 1,500, unit price: 2.27000 EURAggregated transactionsTotal volume: 1,500 Volume weighted average price: 2.27000 EUR 4) TransactionsDate: 18 August 2016Venue: XHELInstrument type: share, CTY1S  ISIN: FI0009002471  Nature of the transaction: acquisitionTransaction details(1) volume: 4,000, unit price: 2.27000 EUR(2) volume: 222, unit price: 2.27000 EUR(3) volume: 778, unit price: 2.27000 EUR(4) volume: 222, unit price: 2.27000 EUR(5) volume: 1,000, unit price: 2.27000 EUR(6) volume: 900, unit price: 2.27000 EUR(7) volume: 1,290, unit price: 2.27000 EUR(8) volume: 193, unit price: 2.27000 EUR(9) volume: 835, unit price: 2.27000 EUR(10) volume: 782, unit price: 2.27000 EUR(11) volume: 1,000, unit price: 2.27000 EUR(12) volume: 981, unit price: 2.27000 EUR(13) volume: 1,000, unit price: 2.27000 EUR(14) volume: 1,430, unit price: 2.27000 EUR(15) volume: 589, unit price: 2.27000 EUR(16) volume: 600, unit price: 2.27000 EUR(17) volume: 786, unit price: 2.27000 EUR(18) volume: 300, unit price: 2.27000 EUR(19) volume: 46, unit price: 2.27000 EUR(20) volume: 3,268, unit price: 2.27000 EUR(21) volume: 5,000, unit price: 2.27000 EUR(22) volume: 1,219, unit price: 2.27000 EUR(23) volume: 820, unit price: 2.27000 EUR(24) volume: 1,300, unit price: 2.27000 EUR(25) volume: 1,661, unit price: 2.27000 EUR(26) volume: 143, unit price: 2.27000 EUR(27) volume: 753, unit price: 2.27000 EUR(28) volume: 1,577, unit price: 2.27000 EUR(29) volume: 870, unit price: 2.27000 EUR(30) volume: 1,800, unit price: 2.27000 EUR(31) volume: 1,914, unit price: 2.27000 EUR(32) volume: 2,461, unit price: 2.27000 EUR(33) volume: 29, unit price: 2.27000 EUR(34) volume: 625, unit price: 2.27000 EUR(35) volume: 227, unit price: 2.27000 EUR(36) volume: 4,773, unit price: 2.26800 EUR(37) volume: 126, unit price: 2.26800 EUR(38) volume: 357, unit price: 2.26800 EUR(39) volume: 1,498, unit price: 2.26800 EURAggregated transactionsTotal volume: 47,375 Volume weighted average price: 2.26971 EUR Helsinki, 22 August 2016CITYCON OYJ For further information, please contact:Anu Tuomola, General CounselTel. +358 50 414 3280anu.tuomola@citycon.com

Ferronordic Machines AB (publ) Interim Report January - June 2016

SOLID RESULT AND EXCITING EXPANSION OF PRODUCT PORTFOLIO SECOND QUARTER 2016 ·  Revenue decreased by 9% (17% increase in rubles) to SEK 405m (SEK 443m) ·  Operating profit increased to SEK 26m (SEK 24m) ·  Operating margin was 6.4% (5.5%) ·  EBITDA amounted to SEK 36m (SEK 44m) ·  The after-tax result amounted to SEK 20m (SEK 14m) ·  Earnings per ordinary share amounted to SEK 0.74 (SEK 0.15) ·  Cash flow from operating activities amounted to SEK 81m (SEK -51m) JANUARY - JUNE 2016 ·  Revenue increased by 3% (28% increase in rubles) to SEK 715m (SEK 696m) ·  Operating profit amounted to SEK 43m (SEK 12m) ·  Operating margin was 6.0% (1.7%) ·  EBITDA amounted to SEK 63m (SEK 52m) ·  The after-tax result amounted to SEK 34m (SEK 3m) ·  Earnings per ordinary share amounted to SEK 0.92 (SEK -2.20) ·  Cash flow from operating activities amounted to SEK 125m (SEK -22m)  SEK M  2016 2015 2016 2015   Q2    Q2    6M    6M Revenue  405.3 443.1 714.9 695.5EBITDA  36.3 44.3 62.9 51.6Operating profit   26.1 24.4 43.2 12.0After-tax result 19.9 14.0 34.2 3.0 Net Debt (178.2) 148.2 (178.2) 148.2Net Debt / EBITDA  (1.3) 1.0 (1.3) 1.0 COMMENTS BY LARS CORNELIUSSON, CEO AND PRESIDENT: · The Russian economy remains weak. The reduction in the market for new construction equipment seems to have slowed down, but the market during the first six months was anyway 10-15% lower than during the same period last year. We do not expect any material changes in the market situation before the end of the year. · Despite of the weak market, we have delivered a relatively strong result for the quarter, including a satisfying cash flow. Even if the revenue was lower than during the second quarter last year, we managed to compensate this primarily by lower costs, resulting in an increased operating profit. Like the last quarter we noted a positive result per ordinary share (which is calculated after dividends on preference shares). Given the difficult market situation, I am very pleased with this result. · After the end of the quarter, we have also been appointed official distributor for Dressta bulldozers and pipelayers all over Russia. The addition of Dressta bulldozers fits perfectly into our product offering and improves our ability to offer full-package solutions to our customers. This is fully in line with our strategy to use our network to distribute complementary products. We also take over responsibility for the aftermarket of the existing machine fleet. · Since the last report we have also refinanced our credit facilities. In total, we now have up to RUB 1,500m of committed financing available from two different banks. Thanks to our net cash position we are not in need of this financing at the moment, but it provides security for the company going forward in these troublesome times. Presentation of second quarter report A presentation of the second quarter report will be held by phone on 23 August 2016 at 9:30 a.m. CET. The presentation can be accessed on the company’s website prior to the meeting. To join the presentation, please dial the phone number no later than five minutes prior to the announced time. Call-in numbers: ·  Sweden Toll Number: 08 5059 6306 ·  Sweden Toll-Free Number: 0200 899 908 ·  UK Toll Number: 0203 139 4830 ·  UK Toll-Free Number: 0808 237 0030 ·  Russia Toll Number: 049 564 693 04 ·  Russia Toll-Free Number: 810 800 2136 5011 Participant code: 76908841#  About Ferronordic Machines  Ferronordic Machines is the authorized dealer of Volvo Construction Equipment and Terex Trucks in Russia. It is also the official Russian distributor of Dressta. In certain regions of Russia, Ferronordic Machines has also been appointed aftermarket dealer for Volvo and Renault Trucks and dealer for Volvo Penta. Ferronordic Machines began its operations in 2010 and has since then expanded rapidly across Russia. The company is well established in all federal districts with almost 70 outlets and approximately 750 employees. The vision of Ferronordic Machines is to be regarded as the leading service- and sales company in the CIS markets. The preference shares of Ferronordic Machines are listed on NASDAQ OMX First North Premier. The company has appointed Avanza Bank AB as its Certified Advisor. http://www.ferronordic.ru For more information, please contact:  Anders Blomqvist, CFO and Head of IR, Tel: +46 8 5090 7280, or pr@ferronordic.ru  Ferronordic Machines discloses the information herein pursuant to the Securities Markets Act and/or the Financial Instruments Act. The information was submitted for publication on 22 August 2016, 11:30 CET.

Half-year Report January–June 2016

· Profit after tax for the period was SEK 1,649 million (1,221), equivalent to SEK 7.99 per share (5.92). The increase is due mainly to higher unrealized changes in the value of the property holdings. · Gross profit increased by 9 per cent, totalling SEK 616 million (565). The increase can be attributed largely to higher rental revenue. · Net revenue amounted to SEK 870 million (822), an increase of 6 per cent. · The fair value of the property holdings was SEK 33.7 billion (31.7 at the turn of the year), resulting in a net asset value of SEK 124 per share (118 at the turn of the year). Unrealized changes in value for the period totalled SEK 1,582 million (1,097). · The equity ratio was 60 per cent (58), the net loan-to-value ratio was 17 per cent (19), and the interest coverage ratio multiple was 8.3 (8.9). · The rental vacancy level at the period-end was 4.2 per cent (6.3). Excluding vacant space resulting from projects in progress, the rental vacancy level was 2.3 per cent (5.1).  Stockholm, August 22, 2016 HUFVUDSTADEN AB (publ)  Ivo Stopner President Appendix: Half-year Report January–June 2016  Questions can be answered by Ivo Stopner, President, or Åsa Roslund, Head of Finance, telephone +46 (0)8-762 90 00.   The information in this Interim Report is information that Hufvudstaden AB (publ) is obliged to publish under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was published under the auspices of the above contact person on August 22, 2016 at 2:45pm. 

Nominations open for the Children's Climate Prize 2016

On a daily basis we hear politicians and scientists speaking about climate change; we hear about ocean acidification, stratospheric ozone, loss of biodiversity, chemical pollution, and aerosols in the atmosphere. Too seldom do we hear positive vibes and hope on the subject. Therefore the time has come to pay attention to the projects and initiatives coming from the next generation: children and young people in Sweden and around the world, climate heroes who refuse to believe in the dystopian predictions and who are fighting tirelessly for a sustainable future, in different ways and on different terms so that we all can live well and prosper in harmony with nature.  On Thursday 24th November 2016 the first ceremony of the newly instituted environmental prize, the Children's Climate Prize, takes place in Sweden. Another well-known Swedish award is the Nobel Prize, the most prestigious one of them all. The Children's Climate Prize is aiming just as high, therefore everything will be carried out just as it would be for the Nobel Prize with the prize ceremony in City Hall with accompanying banquet in impressive surroundings, with prominent guests from all over the world.  The winner of this year's Children's Climate Prize will be announced when chairman of the jury, Johan Kuylenstierna, opens the door to his office at the Stockholm Environment Institute. This will take place the week before the award ceremony.  There will be an opportunity for press and media to be present at the Stockholm Environment Institute for the announcement of this year's winner, please register your attendance with the press officer no later than 22nd October.About the Children's Climate PrizeThe prize is international and anyone can nominate or be nominated. The winner will receive a medal, a diploma and prize money of 50,000 Swedish kronor. The prize is awarded to a child or group of children, ages 10-16, who has, in an exemplary manner, made an extraordinary contribution to the climate and environment. Of all submissions, five will be selected by the jury and announced publicly in early November. One of the five will be the winner of the Children's Climate Prize 2016. The jury consists of Johan Kuylenstierna, director of the SEI, business economist and author Kjell A. Nordström, Sandra Jönsson from WWF Panda Planet, Katarina Mohlin from IF and Soledad Piñero Misa founder of Retoy. Children from France, USA and New Zealand, who participated in the Children's Climate Conference in 2015 will also participate in the jury, as well as students from Blombacka School, class 5, in Södertälje, Sweden. The award ceremony takes place on 24th November which is the anniversary of the Children's Climate Conference  (http://www.telgeenergi.se/privat/kundtjanst/childrensclimateconference/)- the acclaimed climate meeting held in November 2015 in Södertälje, Sweden. When children from all over the world joined forces to put pressure on the world leaders ahead of the climate summit in Paris, COP21. To nominate your contribution to the Children's Climate Prize, please read more here.  (http://childrensclimateprize.org/) Follow us in social media, hashtags #childrensclimateprize #ccprize #ccprize16  Children’s Climate Prize Facebook >> (https://www.facebook.com/childrensclimateprize/?fref=ts) Children´s Climate Prize Twitter >> (https://twitter.com/CCPrize16) Children’s Climate Prize Instagram >> (https://www.instagram.com/childrensclimateprize/) *On the photo from the left: Hanna Gorgis (Blombacka School, Södertälje, Sweden), Johan Kuylenstierna (Stockholm Environment Institute), McKenzie Royo (USA), Katarina Mohlin (IF), Sandra Jönsson (World Wildlife Foundation, WWF), Juliette Potier (France), Soledad Pinero Misa (Retoy), Melina Melkemichel (Blombacka School, Södertälje, Sweden), Kjell A Nordström (business economist and author) och Mikaira Hireme (New Zealand).

GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2016.

Press release Stockholm 22 August 2016           GomSpace (provider of nanosatellites) announces its quarterly results for the second quarter 2016. Stockholm, August 22, 2016. GS Sweden AB announces its interim report for the second quarter of 2016. The report is available on the company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Second quarter summary 1 April - 30 June 2016 (2015) · o    Successful trail of airline tracking in collaboration with Flightradar24 and Airbus Defence. · o    Investment collaboration with IFU on a major satellite project in Africa delivering a constellation of nano-satellites in order to establish a data service company. · o    Agreement signed with DALO and DTU on delivering a nano-satellite based surveillance demonstration for the Arctic. · o    Net revenues increased to SEK 13.9 million (8.0). · o    Gross margin increased to 66% (38%). · o    Profit/loss for the period increased to SEK 0.97 million (negative 2.24). · o    Earnings per share were SEK 0.09 (negative 3.2). 1 January - 30 June 2016 (2015) · o    Net revenues increased to SEK 24.9 million (13.1). · o    Gross margin increased to 65% (28%). · o    Profit/loss for the period increased to SEK 1.45 million (negative 5.84). · o    Earnings per share were SEK 0.25 (negative 8.35). “The result of the first half year of 2016 progressed satisfactory and within our expectations. Our investment program is expected to cause increased expenses and negative profit over the next years, however the underlying profitability seen in the obtained gross margin for GomSpace will stay strong”, CEO Niels Buus commented.     For more information, please contact:                     Niels Buus (CEO)Tel: +45 40 31 55 57                        Email: nbu@gomspace.com  Miscellaneous    +-----------------------------------------------------------------------------+|This information is information that GomSpace is obliged to make public ||pursuant to the EU Market Abuse Regulation. The information was submitted for||publication, through the agency of the contact person set out above, at ||[17:00] CET on August 22, 2016.   |+-----------------------------------------------------------------------------+ About GS Sweden AB The Company’s business operations are conducted through the wholly-owned Danish subsidiary, GomSpace ApS, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on www.gomspace.com.

Viking Supply Ships AB announces changes in the financial calendar.

With reference to previous communication related to the ongoing financial restructuring of Viking Supply Ships A/S: The company has been in discussions with the ad hoc committee of bondholders, representing a majority of the outstanding bonds, regarding an adjusted proposal and has reached an in-principle agreement with the committee. It was expected that the necessary details and approvals of the overall restructuring would be in place to publish the financial report for Q2 2016 on Tuesday 23 August. However, there are still certain outstanding issues in connection with implementation of the global solution.  In order to give a more comprehensive and complete overview of the situation, Viking Supply Ships AB has hence decided to postpone the reporting date for Q2 2016.  The report was according to the financial calendar scheduled for 23 August. The new date for the report is 30 August at 08:30. In conjunction with the publication of the Q2 2016 report, an earnings call will take place on 30 August at 10:00 am (CET). For further information, please see: http://www.vikingsupply.com/investorrelations. For further information please contact:   Ulrik Hegelund, CFO, ph. +45 41 77 83 97, e-mail ulrik.hegelund@vikingsupply.com  Morten G. Aggvin, IR & Treasury Director, ph. +47 41 04 71 25, e-mail ir@vikingsupply.com  Viking Supply Ships AB (publ) is a Swedish company with headquarter in Gothenburg, Sweden. Viking Supply Ships A/S is a subsidiary of Viking Supply Ships AB (publ). In addition Viking Supply Ships AB (publ) has the subsidiary TransAtlantic AB. The operations are focused on offshore and icebreaking primarily in Arctic and subarctic areas as well as on Shipping services mainly between the Baltic Sea and the Continent. The company has in total about 500 employees and the turnover in 2015 was MSEK 1,977. The company’s B-shares are listed on the NASDAQ Stockholm, Small Cap segment. For further information, please visit: www.vikingsupply.com  This information is information that Viking Supply Ships AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 17:30 CET on 22 August 2016. 

Scania – driving the shift towards sustainable transport

The Sustainable Transport Forum in Paris underlines Scania's intention of leading the shift towards a sustainable transport system, a prerequisite for fulfilling the objectives of the Paris agreement and for achieving Sustainable Development. "When we launch the new generation Scania we want to take the opportunity to gather some of the most influential leaders to strengthen the global commitment to achieving sustainable societies," says Mr. Henrik Henriksson, CEO at Scania. Scania wants to use the Transport Forum to highlight the broader context within which we act, and show how the world can go from global agreements to global actions. We are getting closer to the point when it may actually be too late to act. "We need to bend the curve of global CO2 emissions within 4 years and then steeply reduce emissions to reach a fossil free world economy until 2050. For me, it’s no longer a question if humanity will move in a sustainable direction, but if we will manage to do it fast enough. The transportation sector plays a vital role in the transformation that has to happen," says Professor Johan Rockström, Director Stockholm Resilience Centre. Scania also wants to inspire the rest of the industry by focusing on opportunities arising from partnerships and by addressing the world’s next paradigm shift – moving from the industrial to the digital age – along with looking at what challenges need to be faced to achieve true sustainability. "When we look back in some twenty years time, I'm certain we will be able to say that the shift towards sustainable transports started here and that we were a part of the solution. I'm proud that Scania, together with our trusted partners, is leading the way towards a more sustainable future," says Mr. Henrik Henriksson. The Sustainable Transport Forum will be held at Grand Palais in Paris on Tuesday August 23, speakers include: · Mr. Kofi Annan, former secretary General of the UN · Mr. Georg Kell, Founding Director of the United Nations Global Compact · Mrs. Anna Johansson, Swedish Minister for Infrastructure · Mr. Andreas Renschler, Chairman Board of Directors Scania, CEO VW Truck & Bus · Mr. Michael Treschow, former Chairman of Unilever · Professor Johan Rockström, Director Stockholm Resilience Centre · Henrik Henriksson, CEO and President Scania To follow the launch and Forum through Scania’s channels, please visit: nextgenscania.com For further information, please contact Mr. Hans-Åke Danielsson, Press Manager Scania, tel. +46 8 553 856 62.

Gränges completes US acquisition

Gränges acquisition of Noranda’s downstream aluminium rolling business in the United States was closed today, on 22 August, 2016. In order to facilitate the acquisition, Danske Bank and Svenska Handelsbanken have provided Gränges with a credit facility. The acquisition is financed with a five-year term loan equivalent to USD 300 million. In conjunction with the acquisition, Gränges has also refinanced its existing revolving credit facility with a new three-year multi-currency revolving credit facility of SEK 1,200 million. The commitments under the Facilities Agreement are split equally between Danske Bank AS, Danmark, Sverige Filial, and Svenska Handelsbanken AB (publ). Svenska Handelsbanken AB (publ) is acting as Facility Agent for the facilities. For further information, please contact: Pernilla Grennfelt, Director Communications and IR of Grängespernilla.grennfelt@granges.com, tel: +46 702 90 99 55 The information in this press release is such that Gränges must disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on Monday, 22 August, 2016, at 21.30 CET. About GrängesGränges is a leading global supplier of rolled products for brazed aluminium heat exchangers. The company develops, produces and markets advanced materials that enhance efficiency in the customer manufacturing process and the performance of the final products; brazed heat exchangers. The company’s geographical markets are Europe, Asia and the Americas. Its production facilities are located in Finspång, Sweden, and Shanghai, China, and have a combined annual capacity of 220,000 metric tonnes. Gränges has some 950 employees and net sales in 2015 totalled SEK 5,494 million. The share has been listed on Nasdaq Stockholm since October 2014. More information on Gränges is available at granges.com.

BAKKAFROST: Operational EBIT of DKK 307 million for the second quarter of 2016

The Bakkafrost Group delivered a total operating EBIT of DKK 307.1 million for Q2 2016. Harvested volumes were 13.0 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 289.5 million. The farming segment made an operational EBIT of DKK 357.9 million and the increased salmon spot prices had a positive effect on the farming segment. The high salmon spot prices affected the VAP segment negatively, and the VAP segment made an operational EBIT of DKK -68.4 million. The EBITDA for the FOF segment was DKK 45.4 million. The total volumes harvested in Q2 2016 were 13.0 thousand tonnes gutted weight. Bakkafrost transferred 1.9 million smolts in Q2 2016. In Q2 2016, Havsbrún sourced 84.0 thousand tonnes of raw material. The farming segment made an operational EBIT of DKK 357.9 million for Q2 2016, which corresponds to NOK 34.47 per kg. The VAP segment made an operational EBIT of DKK -68.4 million for Q2 2016. The high spot prices in Q2 2016 had a negative effect on the operational EBIT in the VAP segment. The combined farming and VAP segments made an operational EBIT of DKK 289.5 million for Q2 2016, which corresponds to NOK 27.88 per kg. The FOF segment (fishmeal, oil and feed) made an operational EBITDA of DKK 45.4 million for Q2 2016. Commenting on the result, CEO Regin Jacobsen said: “We are very satisfied with the result for Q2 2016. The salmon spot price has been record high in the quarter and the biological performance has been good. The VAP segment has struggled, but we maintain our strategy to sell a share of our production as value added products. The development in our fishmeal, fish oil and fish feed segment in the quarter was also good. The five year investment plan was updated in June on our Capital Market Day, and the hatchery in Viðareiði is starting production at the moment, the new Harvest plant has started operation, and the construction of the new hatchery in Strond has commenced.” On 14 July 2016, Bakkafrost announced suspicion of pathogenic ISA virus in the farming site A-73 Hvannasund Norður based on regular ISA test results, carried out by the Veterinary Authorities according to the Faroese veterinary system. Consequently, Bakkafrost prepared to take necessary actions, and the Veterinary Authority undertook further tests in order to confirm the suspicion of pathogenic ISA virus. After a week of extensive testing, all the results were negative and did not prove the presence of pathogenic ISA virus. After that, the Veterinary Authority increased surveillance at the farming site A-73 Hvannasund Norður and carried out extra tests on neighbouring farming sites, which will be carried out for the next half year. This procedure is stipulated in the Faroese veterinary farming regime with the purpose of securing and maintaining good biology in the Faroese farming industry. Bakkafrost acquired the remaining outstanding shares (51%) in P/F Faroe Farming, effective from 1 July 2016. The Faroese Registry and the Competition Authorities have approved Bakkafrost’s acquisition of P/F Faroe Farming. Simultaneously, Bakkafrost filed (relinquished) two farming licenses to the Faroese Authorities. Following these two transactions, Bakkafrost has 14 licenses for farming salmon in the Faroe Islands. The Bakkafrost Group’s net interest bearing debt amounted to DKK 603.0 million at the end of Q2 2016. Bakkafrost had undrawn credit facilities of approximately DKK 642.8 million at the end of Q2 2016 and the equity ratio was 61% at 30 June 2016. OUTLOOK Market The global demand in the salmon market continues with strong growth rates. The market balance will be tighter in 2016, compared to 2015. Global supply of Atlantic salmon is expected to decrease by approximately 4% in volume during 2016, compared to 2015. The decrease is expected to be 8-9% in the second half of 2016. Production capacity is close to full utilization and further expansion relates to high investments. Farming The outlook for the farming segment is good. The estimates for harvesting volumes and smolt releases are as always dependent on the biological situation. Bakkafrost has acquired the remaining outstanding shares in P/F Faroe Farming, effective from 1 July 2016. P/F Faroe Farming is a salmon farming company and operates in the southern part of the Faroe Islands, Suðuroy. P/F Faroe Farming holds three farming licenses in Suðuroy, Faroe Islands, and the total harvested volumes for 2015 were 4,681 tonnes gutted weight, and the harvested volumes for H1 2016 were 2,054 tonnes gutted weight. P/F Faroe Farming will be consolidated into Bakkafrost Group from 1 July 2016. P/F Faroe Farming expects to harvest 1,000 tonnes gutted weight in the second half of 2016. Together with Bakkafrost’s unchanged expected harvest (excl. Faroe Farming) of 48,000 tonnes gutted weight, the total harvest for Bakkafrost Group in 2016 will be 49,000 tonnes gutted weight. The number of smolts released is one key element of predicting Bakkafrost’s future production. Bakkafrost forecasts a release of 10.4 million smolts in 2016, compared with 11.3 million smolts released in 2015 and 10.4 million smolts released in 2014. The biological situation is Bakkafrost’s most important risk area. The suspicion of possible pathogenic ISA virus in on of Bakkafrost’s farming sites on 14 July 2016 draws the attention to the importance of good animal welfare and biology to reduce the biological risk. Bakkafrost is focusing on the biological risk continuously and has made several new investments and procedures to diminish this risk. VAP (Value added products) Bakkafrost has signed contracts covering around 79% of the VAP capacity for the rest of 2016. This corresponds to around 39% of the expected harvested volumes for the rest of 2016. The remaining 21% are expected to be committed during the period. Bakkafrost has already signed contracts covering approximately 50% of the VAP capacity for 2017. In connection with the negotiation and signing of the new contracts for 2017, Bakkafrost has renegotiated the prices for part of the remaining quantities from the end of Q3 2016 in line with the forward price picture. FOF (Fishmeal, -oil and feed) The outlook for the production of fishmeal and fish oil is dependent on the availability of raw material. The quotas for catching blue whiting in the North Atlantic are expected to be reduced, and therefore the production of fishmeal and fish oil are most likely to reduce in volume in 2016 from relatively high volumes in 2015. Havsbrún’s sales of fish feed in 2016 are expected to be at 80,000 tonnes. Investments In June 2016, Bakkafrost announced a five-year investment plan from 2016 to 2020. The total investments for the period is DKK 2.2 billion, including maintenance CAPEX. The purpose of the investment plan is to continue to have one of the most cost conscious value chains in the farming industry, carry out organic growth, increase flexibility and reduce the biological risk to meet the future consumers’ trends and to be more end-customer orientated. Bakkafrost has a goal to be self-supplied with smolts at a size of 500g each. The benefits are a shorter production time at sea as well as reduced biological risk. To reach this goal, approximately half of Bakkafrost’s total investments over the next five years will be in hatcheries. The investment of the new harvest/VAP factory will be finalised in 2016. The harvest operation has started and the VAP operation is expected to start in Q4 2016. There will be some extra costs during the start-up period, but the investment is expected to result in operational savings of DKK 70-90 million per year with gradual effect from 2017. Bakkafrost plans to increase the value of offcuts from salmon harvested and processed in the new harvest/VAP factory. Bakkafrost will invest in a new salmon-meal and salmon-oil plant, located in Fuglafjørður and operated by Havsbrún. The FOF segment will also invest in a new feed line, which will increase the capacity of the feed production. Financial Improved market balances in the world market for salmon products and cost conscious production will likely improve the financial flexibility going forward. A high equity ratio together with Bakkafrost’s bank financing and the issuance of bonds makes Bakkafrost’s financial situation strong. This enables Bakkafrost to carry out its investment plans to further focus on strengthening the Group, M&A’s, organic growth opportunities and fulfil its dividend policy in the future. Please find enclosed the Company’s Q2 2016 report and presentation. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. About Bakkafrost: Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group operates licenses on 14 farming fjords. The Group has primary processing in Glyvrar, Kollafjørður, Vágur, and secondary processing (VAP) in Glyvrar and Fuglafjørður. The headquarter is located in Glyvrar, and the company has 765 fulltime employees. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan.

Multiconsult ASA second quarter 2016: Good earnings and improved order backlog

EBITDA for the quarter was NOK 92.0 million, an increase of 29.4 per cent compared to the same period last year. The increase is mainly explained by higher net operating revenues arising from the positive calendar effect, and contribution from LINK arkitektur AS. Higher operating expenses, which are in line with increased headcount, partly offset the positive effects. “I am pleased to see that the organization continues to deliver solid results in a competitive market. The new Tønsberg hospital contract award is of significant size and strategic value to us and confirms Multiconsult and LINK arkitektur’s position in the hospital market”, says CEO of Multiconsult ASA Christian Nørgaard Madsen. The order backlog improves at the end of the second quarter and was NOK 1 839.3 million, an increase of 15.0 per cent year on year. The increase is mainly driven by the large, strategic contract award for the new Tønsberg hospital, inclusion of LINK arkitektur AS on 30 September 2015 and solid growth from Transportation & Infrastructure. New contracts awarded during the quarter include the new hospital in Tønsberg, new bus transit lane in Stavanger, and Zanzibar energy sector support project among other. The majority of the order intake was related to new contracts, but important add-ons to and extensions of existing contracts such as Campus Ås and Radisson Blu Hotel Norge in Norway as well as Neelum Jhelum in Pakistan were also recorded in the quarter. Call-offs on frame agreements, such as the important Fosen wind project in Norway, are included when signed. Group balance remains solid as of 30 June 2016 with total assets of NOK 1 279.3 million and total equity of NOK 315.7 million. The group had cash and cash equivalents of NOK 50.0 million, while net interest bearing debt was negative NOK 40.1 million, i.e. an asset. The overall market outlook for 2016 remains fairly robust despite the slowdown in the Norwegian economy. Buildings & Properties is expected to have a modest, but stable growth. The outlook for the architecture market continues to be impacted by significant regional variations. Demand from the Oil & Gas industry is expected to continue at a low level as a result of lower oil prices and lower investment activity on the Norwegian continental shelf. Public sector investment is driving a strong outlook for Transportation & Infrastructure within road and rail. The Energy market remains strong in Norway, especially within transmission and hydropower. International renewable energy markets continue to grow, providing new business opportunities for Multiconsult. Multiconsult’s strong market position, flexible business model and wide service offering provides a sound base for further growth, both domestic and international. A presentation of the second quarter 2016 results will be held today, 23 August, at 09:00 CET at Felix Konferansesenter, Bryggetorget 3, 0250 Oslo. CEO Christian Nørgaard Madsen and CFO Anne Harris will hold the presentation. A live webcast from the presentation can be accessed at www.multiconsult-ir.com and http://webtv.hegnar.no/presentation.php?webcastId=36209034 For further information, please contact:    Investor relations:       Mirza Koristovic, Head of Investor Relations       Phone: +47 93 87 05 25       E-mail: ir@multiconsult.no    Media:       Gaute Christensen, VP Communications       Phone: +47 911 70 188       E-mail: gaute.christensen@multiconsult.no ABOUT MULTICONSULT ASAMulticonsult is a leading Norwegian multidisciplinary engineering consulting company, with more than 2 200 employees and 45 offices in Norway and abroad. The Company focuses on seven market areas: Buildings & Properties, Transport & Infrastructure, Energy, Oil & Gas, Industry, Environment & Natural resources and Architecture. The Company has an operating history that spans more than a century, with the inception of Norsk Vandbygningskontor in 1908. In 2015 Multiconsult completed more than 9 000 projects for approx. 4 000 different customers. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

CLX Communications AB Interim Report Q4 2015/2016

CLX Communications AB (Nasdaq Stockholm: CLX) today reported its results for the fourth quarter of its financial year (2015/2016). Fourth quarter, April – June 2016 · Net sales increased by 24 percent to SEK 290.3 million (234.4). Adjusted for foreign exchange fluctuations the growth was 26 percent. · EBITDA amounted to SEK -1.0 million (10.1). · EBITDA excluding items affecting comparability amounted to SEK 12.0 million (16.4). [1] · EBIT amounted to SEK -2.9 million (8.5). · Net profit for the quarter amounted to SEK -5.8 million (2.9). · Diluted earnings per share amounted to SEK -0.18 (0.10). July 2015 – June 2016 · Net sales increased by 27 percent to SEK 1,074.2 million (844.4). Adjusted for foreign exchange fluctuations the growth was 24 percent. · EBITDA amounted to SEK 65.7 million (93.1). · EBITDA excluding items affecting comparability amounted to SEK 92.7 million (89.1). [1] · EBIT amounted to SEK 58.7 (88.7). · Net profit for the period amounted to SEK 41.9 million (52.9). · Diluted earnings per share amounted to SEK 1.25 (1.77). Significant events during the quarter · The company signed a binding agreement for the acquisition of Mblox Inc. · Extraordinary general meetings resolved on a rights issue to partly finance the acquisition of Mblox Inc. and amendment of the financial year to the calendar year from 1 January 2017. This means that the current financial year will be extended to 18 months.  · During the quarter the Operator Division has had very good order intake and has signed a number of significant deals, including business with a leading mobile phone operator in the Middle East. This deal is worth approximately SEK 32 million and will be recognized as revenue in pace with completion of the project during the next quarters. In addition, the Operator Division closed other deals in the quarter representing approximately SEK 20 million, which will also be recognized as revenue over the coming quarters. Significant events after the end of the period · The acquisition of Mblox Inc. was completed on July 11 and will be included in the Group’s financial statements from this date. The purchase price was USD 117 million on a debt-free basis. At 31 December 2015, Mblox employed 188 people and had sales in 2015 of USD 140 million with EBITDA of USD 6.9 million. Through this acquisition, CLX strengthens its position as one of the global leaders in cloud-based communications services for enterprises and organizations. · To partially finance the acquisition of all shares in Mblox Inc. the company completed a preferential rights issue of 16,216,215 shares to existing shareholders. The issue provided the company with approximately SEK 624 million before issue costs. · The company has also raised new interest-bearing credit facilities of approximately SEK 400 million in order to finance the remainder of the purchase price. 1) For a specification of items affecting comparability, see under “Operating profit” on page 5 in the report. Invitation to report presentation The report will be presented at a phone conference at 10:00 a.m. on August 23. To listen to the presentation, please call +46 (0) 8 852 500 187, stating conference ID 672-050-918. To also be able to ask questions, please follow the meeting online at: https://attendee.gotowebinar.com/register/7774116032550703363 (Webinar ID: 820-856-923). 

Interim report January – June 2016

The second quarter, April – June: · Operating profit/loss: SEK 115.4 million (53.8) · Profit/loss after tax: SEK 86.2 million (37.2) · Earnings per share: SEK 1.71 (0.86) Six months, January – June: · Operating profit/loss: SEK 214.8 million (199.8) · Profit/loss after tax: SEK 172.0 million (175.9) · Earnings per share: SEK 3.72 (4.53) Operating profit for Q1 2015 was positively impacted by approximately SEK 153 million as a result of the revaluation of the Senapsfabriken project during the transfer from associated company to subsidiary. Significant events during the quarter · Acquisition of building rights for around 700 apartments in central Södertälje. The company at the same time sells to SPP Fastigheter 436 rental apartments that will be developed in the project’s first phase. · Sale of 454 rental apartments in the Senapsfabriken project, phase 1 Uppsala, to SEB’s residential fund Domestica III. · Sale of more than 300 rental apartments in the Tegelslagaren and Tegelmästaren projects in Vallentuna to SEB’s residential fund Domestica II. The transaction is conditional on the buyer’s financing and the revenue has thus not been recognized. · Acquisition of the Senapsfabriken project, phase 3 in Uppsala. Magnolia Bostad will pursue the local plan to develop the building rights for the property and intends to build an additional 700 apartments. · Magnolia Bostad wins another two land allocation competitions, one in the new neighborhood in Örebro Municipality, Södra Ladugårdsängen, and one in Åkersberga in Österåker Municipality. The land allocations refer to a total of 410 apartments. · The company has reserved around SEK 28 million in the Nyby Lilium project in Uppsala during the quarter as the company and the Municipality have made different interpretations of the local plan, which resulted in a lower degree of development than previously estimated. · Issue of a secured bond loan for SEK 600 million with an interest rate of STIBOR 3m +6.25 percent, which has been admitted for trading on Nasdaq First North Bond Market. · Employment of additional 12 staff members. For more information, please contact: Fredrik Lidjan, CEO+46 70 223 43 47, fredrik.lidjan@magnoliabostad.se  Erik Rune, vVD/CFO+46 73 399 40 30, erik.rune@magnoliabostad.se The information in this press release is such information that Magnolia Bostad AB is obliged to make public according to the European Union’s Market Abuse Regulation, (EU) No 596/2014, and the Securities Market Act. The information was submitted for publication, through the agency of the contact persons set above, on August 23, 2016 at 7:45 am. Magnolia Bostad develops efficient, attractive and functional residential properties, including rental apartments, tenant-owned apartments and hotels, in attractive locations primarily in Sweden’s growth areas. Our work is based on a holistic approach where the operations are conducted in a manner that promotes long-term, sustainable urban development. Magnolia Bostad's share (MAG) is listed on Nasdaq First North. Erik Penser Bank is the Certified Adviser for the Company. More information is available at www.magnoliabostad.se

Interim report Itiviti Group Holding AB January 1 – June 30, 2016

Steady earnings growth and momentum for new regulatory solutions · Operating revenue for the period from April to June 2016 was SEK 176,644k (170,060), an increase of 4% compared to the same quarter of 2015. Adjusted for foreign exchange effects, operating revenue rose by SEK 4,722k (3%), most of which is explained by the major sale of a perpetual license in the second quarter of 2016 and continued positive development in the APAC region. Product sales are already being driven by products built on our new technology platforms (Tbricks, Catalys) while Itiviti classic products remain stable.  · Adjusted EBITDA was SEK 88,573k (74,243) and EBITDA-CAPEX was SEK 40,105k (32,498). Operating expenses and adjusted CAPEX, adjusted for one-off effects, were SEK 1,023k lower than the same period last year. Adjusted for foreign exchange effects, expenses were SEK 3,618k higher than the same period last year, up by 3%. Most of the increase is explained by higher personnel costs, which have risen primarily due to an increase in the number of employees by around 30 and higher costs for sales commissions. This is offset somewhat by the fact that 2015 was affected by costs for an internal conference that was held in April 2015. The development of Itiviti’s new product offering to facilitate mandatory compliance with MiFID II and other regulations has resulted in higher development costs, which explains the increase in adjusted CAPEX. Comments from CEO Torben Munch: “The investment in our regulatory solutions offering is bearing fruit, as reflected in recent client wins for our market abuse product across Europe. As new regulations are introduced, we see market participants undertaking reviews of their legacy trading systems. As a global, proven and well-capitalized vendor, Itiviti is well positioned to meet the current and future requirements of existing and new customers. Our solutions are based on modern technology that is able to withstand and adapt to future challenges, both regulatory and commercial. To our clients, Itiviti thus offers confidence and certainty in these turbulent times, allowing a continued focus on their core business. Increasingly, clients are discovering the benefits of our new advanced modular technology, and we continue to drive migrations towards the Tbricks by Itviviti/Catalys by Itiviti platforms. In particular, we have signed a number of multi-year contracts with key clients, most of which resulted in broader relationships and demonstrating Itiviti’s commitment to long-term client partnerships. We are also excited about the launch of our new Itiviti website in July. Fully updated in both design and content, it is a source of information about Itiviti and our numerous ongoing initiatives, as well as industry and regulatory trends. The video channel ‘Itiviti Talks’ enables us to effectively share our staff’s wealth of knowledge with anyone interested in the forefront of our dynamic industry.” About ItivitiItiviti is a world-leading technology provider for the capital markets industry. Trading firms, banks, brokers and institutional clients rely on Itiviti’s technology, solutions and expertise to streamline their daily operations, while gaining sustainable competitive edge in global markets. With 13 offices serving more than 400 customers worldwide, Itiviti was formed by uniting Orc Group, a leader in trading and electronic execution, and CameronTec Group, the global standard in financial messaging infrastructure and connectivity. From its establishment in 2016, Itiviti has a staff of 400 and estimated annual revenue of SEK 700 million. Itiviti is committed to continuous innovation to deliver trading infrastructure built for today’s dynamic markets, offering highly adaptable platforms and solutions that enable clients to stay ahead of competitive and regulatory challenges. Itiviti Group Holding AB is owned by Itiviti AB, in which Nordic Capital Fund VII is the principal shareholder. For more information visit: itiviti.com

INTERIM REPORT, January–June 2016

Second quarter of 2016     · Consolidated net sales increased by 9 percent to SEK 522 m (481), of which organic growth amounted to 10 percent. Consolidated net sales were the highest ever for a second quarter. · Net sales in Product & Solutions amounted to SEK 397 m (377) and Installation Services to SEK 156 m (129) · Operating profit (EBIT) before items affecting comparability increased by 27 percent and amounted to SEK 84 m (66), which was the highest ever for the Group in a second quarter · Operating profit (EBIT) amounted to SEK 75 m (59) · Operating cash flow amounted to SEK 41 m (39) · Earnings per share before and after dilution were SEK 2.31 (1.62) January–June 2016 · Consolidated net sales increased by 6 percent to SEK 846 m (800), of which organic growth amounted to 7 percent. Consolidated net sales were the highest ever for a first half of a year. · Net sales in Products & Solutions amounted to SEK 656 m (630) and Installation Services to SEK 236 m (206) · Operating profit (EBIT) before items affecting comparability increased by 38 percent and amounted to SEK 96 m (70), which was the highest ever for the Group in a first half of a year. · Operating profit (EBIT) amounted to SEK 83 m (80) · In accordance with the usual seasonal variations, the operating cash flow was negative, in the amount of SEK -10 m (-21) · Earnings per share before and after dilution were SEK 2.32 (2.03) Message from the CEOStrong sales growth and significant improvement in earningsNordic Waterproofing Group’s business grew strongly in the second quarter of 2016, which was our first quarter as a listed company in the Mid Cap segment on Nasdaq Stockholm. Consolidated net sales rose by 9 percent and EBIT before items affecting profitability increased by 27 percent compared with the corresponding period in 2015.This performance, combined with our good first quarter, makes for a record first half year in the history of our Group, with sales up 6 percent and EBIT before items affecting profitability up 38 percent compared with the corresponding period in 2015. Our focus is on continuing to provide best-in-class customer service, product quality and logistics solutions. Our performance is driven by the expertise and high level of motivation among our workforce. We continue to look forward to a good full-year for Nordic Waterproofing Group.Nordic Waterproofing is one of Northern Europe's leading producers and providers of products and related services for waterproofing, protecting and preserving buildings and infrastructure.Consolidated net sales in the second quarter of 2016 showed growth of 9 percent compared to the corresponding period in 2015, from SEK 481 m to SEK 522 m, with both of our operating segments contributing. While our Products & Solutions operating segment picked up steam with a sales increase of 5 percent, our Installation Services operating segment reported a particularly strong performance with an increase of 22 percent, following an improving demand picture in Finland. Denmark continues to see a stable favorable demand trend. The Swedish market is continuing its robust development, although we noted a slightly weaker demand in the DIY sales channel, and in our sales of infrastructure project-related products. Our sales in Norway are back on track to a significantly positive growth trend, after a somewhat slower first quarter. The Finnish market has confirmed the early signs of growth seen since the beginning of the year, driven primarily by customers' projects in the Helsinki region.The Product & Solutions operating segment reported significant growth and an improved margin as the result of an increase in sales volumes combined with a continued focus on cost optimization. The period saw relatively low prices of oil and bitumen, albeit somewhat higher than during the first quarter.The Installation Services operating segment reported improved results, primarily due to better volumes in our Finnish operations. Our total order book for Installation Services remains at a high level compared to the corresponding period in 2015. The business in this operating segment is primarily conducted in Finland and through franchise companies in Denmark.In conclusion, we believe that the encouraging results obtained during the first six months of 2016 confirm the validity of our business model. We intend to continue strengthening our positions in our core markets, and evaluating growth opportunities in selected countries and market niches.Vejen, 23 August 2016 Martin EllisPresident and CEOConference callA conference call for investors, analysts and media will be held today at 10:00 a.m. CET and can be joined online at www.nordicwaterproofing.com. Presentation material for the call will be available on the website one hour before the call. To participate, please dial:From the United Kingdom:       +44 20 3008 9808From Denmark:                         +45 35 44 55 76From Sweden:                           +46 8 566 425 09 Further information can be obtained fromMartin Ellis, President and CEO, tel: +45 3121 3669Jonas Olin, CFO, tel: +46 708 29 14 54Anders Antonsson, Investor Relations, tel: +46 709 99 49 70This information is information that Nordic Waterproofing Holding A/S is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 23 August 2016, 08:00 p.m. CET.

Eltel’s power transmission business wins five new contracts in Finland at a total value of approximately EUR 18 million

The new contracts cover the following projects: · Extension of Fingrid’s 220/110 kV substation in Seitenoikea. The project will be completed by October 2017. · New 110/20 kV substation in Gunnarnäs, refurbishment and modernisation of the Vikom 110/20 kV substation and refurbishment and modernisation of the substations in Hanko, Lappohja and Lindsby as well as construction of the power lines Karjaa – Åminnefors and Karjaa – Lappohja, all for Caruna. The projects are planned for completion by the end of 2018. · Refurbishment of Elenia’s 110 kV power line Nivala – Hitura with new 2x110 kV line with a completion during summer 2017. Fredrik Menander, President – Power Transmission, Eltel AB comments:“These contracts confirm our strengthened market position for substations in the Nordics. Eltel is, since many years, one of the substation market leaders in Poland and we started the Nordic market entry with Finland in 2014. We have since then shown that Eltel is a competent and trustworthy partner to execute substation projects in Finland while executing other ongoing substation projects also in Sweden, Norway and Germany. Furthermore, we are very happy having been selected as the partner by Caruna and Elenia for their overhead line projects. The contracts above illustrate the continuous investments done in the grids in order to secure undisturbed transport of electricity”.  For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com  Hannu TynkkynenDirector – External Communications and SustainabilityTel: +358 40 311 4503, hannu.tynkkynen@eltelnetworks.com   About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Tele2 IoT acquires Kombridge AB and strengthens its position within security services

Kombridge brings a number of valuable assets and Tele2 IoT will immediately strengthen its security portfolio through the Kombridge Connect security product. The combined sales and technology teams will build upon Kombridge’s technology and knowledge to establish even stronger value added services for B2B application- and connectivity management. As part of the acquisition, Tele2 IoT obtains Kombridge’s current customer base, product portfolio as well as its six employees with great IoT competence and track-record to maximize sales and development synergies. Rami Avidan, Managing Director, Tele2 IoT, comments: “We are extremely excited to welcome the Kombridge team to the Tele2 IoT family. The two companies have worked close to each other for a long time. Hence, we know each other well and are very confident that our combined strengths will make us an even stronger global IoT player with high value creation for our customers and partners.” For more information, please contact:Viktor Wallström, Communications Director, Tele2 AB, Phone: +46 703 63 53 27Louise Tjeder, Head of Investor Relations, Tele2 AB, Phone: +46 704 26 46 52TELE2 IS ONE OF EUROPE'S FASTEST GROWING TELECOM OPERATORS, ALWAYS PROVIDING CUSTOMERS WITH WHAT THEY NEED FOR LESS. We have 16 million customers in 9 countries. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2015, we had net sales of SEK 27 billion and reported an operating profit (EBITDA) of SEK 5.8 billion.  For definitions of measures, please see the last page of the Annual report 2015.

Top line results from the Swedish ongoing Phase II study with IdeS in sensitized patients presented

The ongoing and fully recruited Phase II study at Uppsala University Hospital and Karolinska University Hospital in Huddinge, Sweden, includes 10 patients who received a single dose of IdeS (0.25 or 0.5 mg/kg) before kidney transplantation. The study’s primary focus is to evaluate safety and tolerability of Hansa Medical’s candidate drug IdeS in sensitized kidney transplantation patients. The study is also aimed at identifying an IdeS dose that results in anti-HLA antibody levels acceptable for transplantation within 24 hours from dosing.  Patients in the study are followed for six months after transplantation to continue to evaluate drug safety and kidney function.  The study is expected to be finalized in Q4 2016. Professor Tufveson concludes in his presentation that IdeS treatment is a suitable way to achieve rapid and effective desensitization allowing transplantation in immunized patients and that a dose level of 0.25 mg/kg body weight is a suitable dose. Two additional clinical studies with IdeS in sensitized patients are ongoing: an investigator initiated Phase II study at Cedars-Sinai Medical Center in Los Angeles and a pivotal multicenter study in the US with IdeS in refractory highly sensitized patients. Results from the multicenter study hold the potential to form the basis for filing a Biologics License Application, which is an application to the US Food and Drug Administration (FDA) for authorization to commercialize IdeS in the US. In addition, Hansa Medical is evaluating the possibility of adding various European sites to this multicenter study to better support the regulatory process at the European Medicines Agency, EMA, to gain marketing authorization of IdeS in the European market.  The information in this press release is disclosed pursuant to the EU Market Abuse Regulation. The information was released for public disclosure through the agency of the contact person stated below on  August 23, 2016 at 08.30 CET.

Going for Gold at Castle Howard – glistening crowning glory for famous dome

When complete, it will glisten in the sun to be seen from miles around.  That’s the promise from the Hon. Nicholas Howard to mark the start of the gilding process on the lantern which sits atop Castle Howard’s famous dome. Visitors to Castle Howard over the last couple of weeks will have seen scaffolding covering the lantern – the decorative feature which sits on top of the dome – as the wooden finial, cornice and windows of the lantern were prepared for the work, which will see sheets of 23.5 carat gold leaf applied to the woodwork to give an unrivalled shine.  The work can only be done in good weather to ensure that the gold leaf forms an effective shield against moisture – preserving the longevity of the cupola’s crown. “The lantern is the crowning glory which sits on top of Castle Howard’s dome, and when finished, the highly-reflective gold leaf will be visible from miles around,” explains Nicholas Howard, who has commissioned the work.  “In the past, different materials and techniques have been used to give the lantern its golden hue, but experience shows that only high quality gold leaf provides the glistening finish that can be seen in 18th century paintings of the building.” The gilding work will focus upon three sections – an apex finial which is just less than three metres high, the cornice and, below that, the lantern which has windows enabling the top of the dome to be a beacon by night as well as by day.  Although it may appear much smaller when viewed from ground level, the area to be gilded is approximately 32 square metres.  The sheets of gold leaf are painstakingly applied in sheets of 20cm square – up to 1000 will be used to complete the task – and fixed using a special oil-based adhesive.  “Approximately 1,000 sheets will be used, but the gold leaf is so thin that the entire weight of the gold used comes to a mere 16 grams.  This would be roughly equivalent to the weight of a medium-sized bracelet; or if it was rolled into a ball it would be a similar size to a marble.  The purity of the gold ensures that it will not tarnish, so there is no need to use a dulling sealant over the top – it will retain its shine and lustre for many years, whilst protecting the wood underneath from the elements,” adds Mr Howard. The dome is Castle Howard’s defining architectural element. The enormous lead-lined cupola rises up from the stone drum which is surrounded by a ring of gigantic busts. The apex to the building is the small wooden lantern above the cupola, which in turn has its own little cap topped by a large carved finial. The lantern and finial together stand five metres high.  The last time the dome was covered in gold leaf was in 1997, and before that in 1961 when the dome has been rebuilt after the fire of 1940. Subject to favourable weather conditions, the scaffolding should be removed in mid-to-late September, when the golden crown on the majestic building will be revealed once again. For more information, please visit www.castlehoward.co.uk ENDS Notes to editors: The gilding process is expected to take between a week and 10 days, and started on Thursday 18 August.  Prior to that, timber repairs and surface preparation – including painting the surface with a custard-yellow protective paint and filler – have taken place. The gilding is being undertaken by Hull-based Lightowler, which has two specialist gilders as part of its team. +----------+-----------------------+|Issued by:|Jay Commins, Pyper York|+----------+-----------------------+|Date: |23 August 2016 |+----------+-----------------------+|Telephone:|01904 500 698 |+----------+-----------------------+|Email: |jay@pyperyork.co.uk |+----------+-----------------------+

Sino Agro Food Inc. Reschedules Conference Call

August 23, 2016 GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME) Due to a late scheduling conflict, the Company has postponed its second quarter 2016 conference call to Friday, September 2, 2016 at 10:00 AM EDT/4:00 PM CET. The dialing instructions remain unchanged, as below. The Company appreciates your understanding and apologizes for any inconvenience resulting from this change. Earnings Call Information To participate in the conference call please use the following information: +-----------------------+-------------------------------+|SIAF 2016 Q2 Results ||Call Information |+-----------------------+-------------------------------+|Date: September 2, 2016|Time: 10:00 AM, EDT/4:00 PM CET|+-----------------------+-------------------------------+|Participant Dialing ||Instructions: |+-----------------------+-------------------------------+|SE:       +46 8 5059 63|UK:      +44 203 139 48 30 ||06 |CN:      +86 400 681 54 21 ||NO:      +47 23 50 05 | ||59 | ||US:      + 1 (866) 928 | ||-7517 | |+-----------------------+-------------------------------+|Conference ||Pincode 33780765#The ||earnings call will also ||be available over the ||web.To access, click ||the following link:  || Sino Agro Q2 2016 ||Earnings ||Call (https://wonderland ||.videosync.fi/2016-08 ||-18-sino-agro-food-q2 ||-report)   |+-----------------------+-------------------------------+

Scania introduces new truck range

Scania is introducing a new truck range, the result of ten years of development work and investments in the region of SEK 20 billion. With the new range, Scania is extending its offering and can now, thanks to its unique modular system, supply more performance stages, connectivity and a comprehensive palette of productivity-enhancing services as well as sustainable transportation solutions that are precisely customised for each type of customer in the highly comp­etitive transportation industry. The promise is that Scania's customers will always be able to carry out their work in the most sustainable and profitable way, regardless of industry and area of application. "It is undoubtedly the biggest investment in Scania's 125 year history," declares Henrik Henriksson, President and CEO of Scania. "It is with hearts bursting with pride that my colleagues and I are now presenting the products and services that will bring Scania to new levels regarding market shares and carry us far into the next decade. "Today we are not just launching a new truck range but also a unique, ingenious toolbox of sustainable solutions in the form of products and services that Scania is first in the industry to be able to deliver – and I feel I can claim this with confidence. We are focusing firmly on our main task: to give our customers the necessary tools for achieving profitability in the one business that really means something to them, namely their own." Production of the new trucks starts immediately at Scania's final assembly plant in Södertälje. Initially the focus will be on vehicles and services for long-haul transportation, but additional options will be continually introduced as more Scania plants readjust and additional options emerge. "There is a tremendous amount of development work by our engineers behind this introduction," emphasises Henrik Henriksson, Scania's President and CEO. "The most noticeable features are of course the new cabs, but the real innovation is that we are now introducing new technologies, services and insights that will help our customers gain an overview of both their costs and their revenues. Our goal is for our customers to be able to achieve sustainable profitability, regardless of assignment type or the conditions in which they work. Our customers' vehicles always constitute a link within the bigger picture; Scania embraces this through quality, accessibility and a range of physical or connected services. Our new range of products and services re­defines the term ‘premium’ within the truck industry." Scania is launching its new range in phases, with a clear focus on various customer segments and according to a carefully planned schedule. The introductions will continue after the first unveiling in Europe, with more customer options, before the entire process concludes with simultaneous launches on markets outside Europe. Among the improvements Scania is introducing, one that is particularly noticeable is a 5% reduction in diesel fuel consumption, thanks to factors such as improved powertrains and better aerodynamics. The express goal is for at least 40,000 customers and prospective customers to have test driven the new vehicles themselves in connection with the launches, and to have been introduced to Scania's entire range, covering everything from sustainability optimisation to financing, insurance and maintenance. Other channels are online communication, the media and Scania's approximately 1,700 dealers in more than 100 countries. The unveiling was held earlier tonight in Paris, live in front of roughly 1,500 special guests and globally to the online community. For further information, contact: Örjan Åslund, Head of Product Affairs, Scania Trucks, tel. +46 (0)70 289 8378, email orjan.aslund@scania.com 

NORDIC NANOVECTOR ASA – RESULTS FOR SECOND QUARTER AND HALF YEAR 2016

Oslo, Norway, 24 August 2016 Nordic Nanovector ASA (OSE: NANO) announces its results for second quarter and half year 2016. A presentation of the results by the company’s senior management team will take place today at 8:30 a.m. CEST in Oslo - details below. Nordic Nanovector has continued to make good progress in executing its clinical development plan for Betalutin®. Patient recruitment is on track and all study sites have been recruited. Given this progress, Lymrit 37-01 study remains on track to define the optimized dose regimen to be used in PARADIGME, the pivotal Phase 2 study that is planned to start in 2H 2017. Updated data from this ongoing clinical study, presented at AACR in April, confirmed Betalutin®’s efficacy potential, durability of response and favourable safety profile in patients with advanced FL. The company continues to advance its product pipeline. Nordic Nanovector is ready to initiate its Phase 1 clinical study for Betalutin® in diffuse large B cell lymphoma (DLBCL) having received clearance of the Investigational New Drug (IND) Application from the FDA and acceptance of the protocol design from EU Authorities. Nordic Nanovector has signed two research and development collaborations with Paul Scherrer Institute and AREVA Med with the goal of developing new Antibody-Radionuclide-Conjugates (ARCs) for treatment of single cell leukaemias. The company has received a grant of up to NOK 15 million from the Research Council of Norway’s User-driven Research-based Innovation programme to support the discovery and development of novel targeted therapeutics for leukaemias and non-Hodgkin lymphoma (NHL). Luigi Costa, CEO of Nordic Nanovector, comments: “The first half of 2016 has been very positive for Nordic Nanovector and continues the positive momentum of 2015. We are pleased to report the continued good progress with the Lymrit 37-01 study as we remain on track to define the optimized dose regimen to be used in the pivotal Phase 2 study that is planned to start in 2H 2017. The updated results from Betalutin® in FL that were presented at AACR reinforce our belief in its promise to become a significant new treatment of NHL. We have also made good progress across all other key areas, including signing two new R&D collaborations to develop new ARCs for the treatment of leukemias.  We believe we are now well positioned to achieve our goal of becoming a leader in the development of targeted ARCs for haematological cancers.” Operational Highlights Q2 and First Half 2016 • Clinical study on Betalutin® in FL on track to meet timelines for selection of optimal dose regimen for the pivotal Phase 2 PARADIGME trial • Updated clinical results presented in April continue to show Betalutin®’s promising efficacy and increasing Duration of Response • Preparations towards initiation of clinical studies of Betalutin® in second NHL indication, DLBCL • Progress on advancing platform to deliver future pipeline products; R&D collaborations entered with Paul Scherrer Institute  and AREVA Med to develop new ARCs targeting leukaemias • New Chief Medical Officer signed on • Board of Directors strengthened further with international experts in development and commercialization of innovative cancer therapies Post Period Event • Completed recruitment of the first cohorts of Arm 3 and Arm 4 of expanded Phase 1/2 study of Betalutin® in NHL patients  Financial Highlights Q2 and First Half 2016 (Figures in brackets = same period 2015 unless otherwise stated) • Revenues for the second quarter amounted to MNOK 0.079 million (MNOK 0.142). Revenues for the first half of 2016 were MNOK 0.157 (MNOK 0.218). • Total operating expenses for the second quarter were MNOK 48.1 (MNOK 51.2). Total operating expenses for the first half of 2016 amounted to MNOK 100.9 (NOK 87.1) • Comprehensive loss for the second quarter amounted to MNOK 51.1 (loss of MNOK 47.7). Comprehensive loss for the first half was MNOK 115.2 (MNOK 81.4) • Cash and cash equivalents amounted to MNOK 618.4 at the end of June 2016 (MNOK 671.9 at 31 March 2016 and MNOK 743.4 at 31 December 2015) Outlook Nordic Nanovector is committed to develop, manufacture and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The market landscape for the company’s lead drug candidate Betalutin® is promising. Strong results and good progress in the Phase 1/2 study in addition to encouraging findings from the research and development pipeline bode well for Nordic Nanovector’s future. Management will continue to focus its efforts on the efficient execution of its plans and to meet anticipated clinical milestones. Current cash resources are expected to be sufficient to reach the first regulatory submission for Betalutin® in FL in the first half of 2019.     Presentation and webcast details A presentation by Nordic Nanovector’s senior management team will take place today at 8:30 a.m. CEST at: Thon Hotel Vika Atrium Munkedamsveien 45 0250 Oslo Meeting Room: NYLAND The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investor Relations/Webcast. The results report and the presentation will be available at www.nordicnanovector.com in the section: Investor Relations/Reports and Presentation/Quarterly Reports/2016 from 7:00 am CEST the same day.  For further information, please contact: IR enquiries: Luigi Costa, Chief Executive Officer Cell: +41 79 124 8601 Tone Kvåle, Chief Financial Officer Cell: +47 91 51 95 76 Email: ir@nordicnanovector.com Media enquiries: Mark Swallow/David Dible (Citigate Dewe Rogerson) Tel: +44 207 282 2948/+44 207 282 2949 Email: nordicnanovector@citigatedr.co.uk About Nordic Nanovector Nordic Nanovector is a biotech company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology. The Company’s lead clinical-stage product opportunity is Betalutin®, the first in a new class of Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market worth over $12 billion by 2018. Betalutin® comprises a tumour-seeking anti-CD37 antibody, lilotomab (previously referred to as HH1), conjugated to a low intensity radionuclide (lutetium-177). The preliminary data has shown promising efficacy and safety profile in an ongoing Phase 1/2 study in a difficult-to-treat NHL patient population. The Company is aiming at developing Betalutin® for the treatment of major types of NHL with first regulatory submission anticipated in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies. The Company is committed to developing its ARC pipeline to treat multiple selected cancer indications. Further information about the Company can be found at www.nordicnanovector.com Forward-looking statements This announcement may contain certain forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on Nordic Nanovector’s business, financial condition and results of operations. The terms “anticipates”, “assumes”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “might”, “plans”, “should”, “projects”, “will”, “would” or, in each case, their negative, or other variations or comparable terminology are used to identify forward-looking statement. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied in a forward-looking statement or affect the extent to which a particular projection is realised. Factors that could cause these differences include, but are not limited to, implementation of Nordic Nanovector’s strategy and its ability to further grow, risks associated with the development and/or approval of Nordic Nanovector’s products candidates, ongoing clinical trials and expected trial results, the ability to commercialise Betalutin®, technology changes and new products in Nordic Nanovector’s potential market and industry, the ability to develop new products and enhance existing products, the impact of competition, changes in general economy and industry conditions and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Nordic Nanovector disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act.

SCA plans to split the Group into two listed companies in 2017, hygiene and forest products

In August 2015, SCA announced that, in order to further develop the Group’s two operations, SCA had decided to initiate a dividing of the Group into two divisions: a hygiene division and a forest products division.  “For the Annual General Meeting 2017, the Board of Directors plans to present a proposal for the distribution and listing of the company's hygiene business”, says Pär Boman, Chairman of the Board of Directors of SCA. “Our hygiene and forest products businesses are two strong operations with attractive offerings in their respective industries. After a thorough analysis, our conclusion is that a split of SCA into two listed companies is the best way to continue to create shareholder value, customer benefits and further development opportunities”, says Magnus Groth, President and CEO of SCA. An evaluation, mainly based on value creation and flexibility for the shareholders, has been made of various methods and structural alternatives to achieve a complete split of the two businesses into two independent companies. The conclusion is that a distribution and listing of SCA's hygiene business will create more shareholder value and incur relatively low transactional risk and relatively low transaction costs. “It is the Board of Directors´ opinion that the proposal to split the hygiene and forest products businesses into two listed companies increases the ability for each business to successfully realize its strategies and increase value for SCA's shareholders. It is also pleasing that the main shareholders will support the proposal at the Annual General Meeting”, says Pär Boman Chairman of the Board of Directors of SCA. “As a long-term asset manager and active owner in SCA we share the company’s opinion that a dividing of the business creates value over time. It is a natural step in the successful streamlining towards the hygiene business and the forest products business conducted over several years, says Helena Stjernholm”, CEO, Industrivärden. Prior to the Annual General Meeting 2017, the Board of Directors plans to present a proposal for the distribution and listing of the Group's hygiene business. The distribution is proposed to be made to the shareholders in proportion to their holdings of SCA's Class A and Class B shares. The distribution is expected to meet the requirements of Lex Asea. If the shareholders decide in favor of the proposal, the plan is to distribute and list the new hygiene company on Nasdaq Stockholm during the second half of 2017. Following a split, there will be two listed companies. One will be a hygiene company including SCA's current business areas Personal Care and Tissue. The second, a forest products company including all forest products operations and all the forest land owned by the SCA Group. “SCA's leading global hygiene business offers products that make life easier every day for millions of people around the world. An increasing awareness of the relationship between hygiene and health, combined with a growing and aging population, are creating greater demand for hygiene products. Furthermore, SCA is Europe's largest private forest owner and the well-integrated supply chain, with production facilities concentrated in Sweden in close proximity to its forest holdings, offers significant synergies and competitive advantages. Forest Products is an efficient and well-invested business. Our investment in increased pulp capacity in the Östrand mill, one of the largest industrial investments in Sweden, will further strengthen our long-term competitiveness”, says Magnus Groth, President and CEO of SCA. Effective immediately, SCA's Directors appointed by shareholders and CEO, Magnus Groth, have, in addition to current assignments also been appointed the Board of Directors and CEO of the parent company for the hygiene business. The intention is to appoint Ulf Larsson, current President of SCA Forest Products and a member of the Executive Management Team, CEO of the listed forest products company after the distribution of the hygiene business. Effective immediately, the Board of Directors has also appointed Ulf Larsson, in addition to current assignments, Executive Vice President of SCA. The intention is that the new listed hygiene company receives a new name and is registered in Stockholm and the forest products company keeps the name SCA and is registered in Sundsvall. Conference call A conference call, held in English, for media, analysts and investors will be held today at 09:30 CET by Magnus Groth, President and CEO of SCA. The conference call will be live webcasted at www.sca.com. You can also participate by telephone, call: +1 646 934 6795, +44 (0)207 1620 177 or +46 (0)8 5052 0114. Specify "SCA" or conference id 959885. Please call in good time before the conference starts. Facts SCAs businesses 2015 +--------------+----------------+------------------------+| |Hygiene business|Forest products business|+--------------+----------------+------------------------+| | | |+--------------+----------------+------------------------+|Net sales |SEK 98,528m |SEK 17,279m |+--------------+----------------+------------------------+|Adjusted |SEK 11,207m |SEK 2,605m ||operating | | ||profit1  | | |+--------------+----------------+------------------------+|Capital |SEK 68,201m |SEK 37,217m ||employed2  | | |+--------------+----------------+------------------------+|Average number|39,898 |4,153 ||of employees | | |+--------------+----------------+------------------------+|Sales in |Approx. 100 |Approx. 50 ||number of | | ||countries | | |+--------------+----------------+------------------------+|1Excluding | ||items | ||affecting | ||comparability | ||and common | ||Group expenses | ||2 Excluding | ||common Group | ||items | |+--------------+----------------+------------------------+ *Lex Asea is a tax regulation in Sweden. This provision means that if a parent company distributes shares in a wholly owned subsidiary to its shareholders, then the taxation of the capital gain the shareholders may enjoy in connection to the distribution under certain circumstances be postponed until the time when the shareholder in turn sells the received shares. NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation or the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 07:30 CET on August 24, 2016. Karl Stoltz, Media Relations Manager, +46 8 788 51 55

Second quarter report 2016

24 August 2016 · Net sales increased by 12 percent to MSEK 1,503.5 (1,341.3), and by 15 percent at constant exchange rates. The increase refers mainly to Norway and Sweden. Net sales for comparable units, i.e. excluding Finland and Sødams in Denmark, increased by 12 percent at constant exchange rates. · Adjusted operating income* declined by 4 percent to MSEK 74.3 (77.0), corresponding to a margin of 4.9 (5.7) percent. Adjusted operating income increased in Norway and Sweden, but declined in Denmark. Adjusted operating income for comparable units increased by 11 percent. · Income for the period amounted to MSEK 38.8 (45.7) and earnings per share were SEK 0.65 (0.76). · Adjusted operating cash flow* declined to MSEK 33.1 (136.0) due to higher capital expenditure, which was also more phased to the first half of the year than in 2015, and an increase in working capital compared to a significant decrease in 2015. +-------------------------------+-------+-------+------+-------+-------+------+|MSEK |Q2 2016|Q2 2015|Change|H1 2016|H1 2015|Change|+-------------------------------+-------+-------+------+-------+-------+------+|Net sales |1,503.5|1,341.3| 12%|2,889.9|2,650.9| 9%|+-------------------------------+-------+-------+------+-------+-------+------+|Operating income | 74.3| 72.8| 2%| 141.5| 140.4| 1%|+-------------------------------+-------+-------+------+-------+-------+------+|Income for the period | 38.8| 45.7| -15%| 81.1| 87.3| -7%|+-------------------------------+-------+-------+------+-------+-------+------+|EPS, SEK | 0.65| 0.76| -15%| 1.36| 1.45| -6%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted EBITDA* | 123.4| 123.8| -0%| 238.5| 237.8| 0%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating income* | 74.3| 77.0| -4%| 142.6| 144.6| -1%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating margin* | 4.9%| 5.7%| -| 4.9%| 5.5%| -|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted income for the period*| 38.8| 49.0| -21%| 82.0| 90.6| -10%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted EPS*, SEK | 0.65| 0.82| -21%| 1.38| 1.51| -9%|+-------------------------------+-------+-------+------+-------+-------+------+|Adjusted operating cash flow* | 33.1| 136.0| -76%| 69.8| 236.3| -70%|+-------------------------------+-------+-------+------+-------+-------+------+ *) Adjusted for non-comparable items in Q2 2016 of MSEK - (-4.2) in EBITDA and operating income and MSEK - (-3.3) in income for the period, and for H1 2016 of MSEK -1.1 (-4.2) in EBITDA and operating income and MSEK –0.9(-3.3) in income for the period. See page 3. CEO Statement  Net sales showed strong growth in the quarter with an increase of 15 percent at constant exchange rates, which was significantly above the growth in the market. The increase referred mainly to additional distribution in Norway in combination with a strong recovery of the Norwegian market, strong growth in Sweden in chilled products and a significant number of new listings in Finland.   We successfully launched a number of new products in order to drive the category in line with our vision to inspire the Nordic consumers to eat chicken once more per week. These included for example tasty sausages, marinated barbeque products, inner filets on sticks and chicken bacon. Despite the strong growth in net sales, the adjusted operating margin for the Group declined from last year. This was mainly due to a decline in income for the Danish operation as well as costs for ramping up production in Finland. Furthermore the operation in Finland was included for the full quarter this year compared to only one month in 2015. We also had additional costs in Sweden to meet the strong demand and to maintain service levels at the same time as the Valla facility was rebuilt for higher capacity. Adjusted operating income for comparable units increased from last year. Adjusted operating cash flow declined as capital expenditure was higher than last year to secure capacity in Sweden and was also more phased to the first half of the year than in 2015. Working capital showed an increase compared to a significant decline last year. Net sales for the Swedish operation showed strong growth in chilled products and the Group strengthened its market share in this category. The adjusted operating margin was unchanged from last year as additional costs mentioned above had a negative impact. We are working on increasing both efficiency and capacity in production. The rebuilding of the Valla facility is expected to be finalised during the third quarter this year. The strong increase in net sales for the Norwegian operation referred to the new contract with COOP Norway. Deliveries under this contract started in August 2015. We also signed a new contract with NorgesGruppen earlier this year under which deliveries started in the first quarter 2016. The retail market for chicken products in Norway showed a continued recovery and grew by approximately 13 percent in value in the quarter compared to a decline by 4 percent last year. Adjusted operating income and margin for the Norwegian operation improved. The market share was strengthened from last year. Net sales for the Danish operation were higher than last year but the adjusted operating margin declined due to continued price pressure in both the local market and on exports. The majority of sales for the Danish operation refers to exports. Our efforts in product development will allow us to gradually expand our presence in the premium segment in the local market where Danpo is the leading brand, and also to offer more of further processed products for export. In the quarter we started to supply one of Europe’s leading foodservice providers with further processed products. As communicated in March, Mark Hemmingsen took over as new country manager as of August 1. I want to welcome Mark to the Group and I am convinced that his experience in consumer products and brand building will contribute to profitable growth for the Danish operation. Volumes for the Finnish operation more than doubled quarter over quarter as a result of new and extended customer contracts. The retail market for chicken products in Finland grew by approximately 14 percent in value in the quarter compared to last year. Adjusted operating income remained negative, however, due to additional costs for handling inefficiencies and bottlenecks in production as volumes were significantly ramped up to meet demand. We are taking a number of actions to improve productivity in the facility and expect to see a gradual improvement over the coming quarters. We expect continued good growth in market demand and have great opportunities to grow net sales and develop the category. We are working hard to take advantage of this growth and at the same time improve the Group's results and financial position. Leif Bergvall HansenManaging Director and CEO Further informationFor further information, please contact: Leif Bergvall Hansen, Chief Executive Officer Tel: +45 22 10 05 44Tobias Wastensson, Head of Group Finance Tel: +46 10 456 14 86    Financial calendar ·  Interim report for the third quarter 2016: 3 November 2016 This interim report comprises information which Scandi Standard is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 07:30 CET on 24 August 2016.

David Nuutinen steps down as CEO – search for new CEO initiated

“David Nuutinen has been a successful and appreciated leader in Cloetta during his thirteen years with the company, including the last year as CEO. Therefore, I very much regret that he has decided to leave Cloetta and on behalf of the Board I would like to express our sincere thanks and appreciation to David for his dedication and excellent work for the company”, says Lilian Fossum Biner, Chairman of the Board of Directors. “I am very pleased with Danko Maras taking the role as interim CEO. He is very experienced and has been with the company for many years and will together with the Group Management Team make sure that we continue to drive profitable growth. Strategy and financial targets therefore remain intact”, says Lilian Fossum Biner. David Nuutinen will be available to support the Board and the management team during his term of notice of six months. Conference callA conference call with Lilian Fossum Biner, Chairman of the Board of Directors, David Nuutinen, outgoing President and CEO, and Danko Maras, incoming interim President and CEO will be held today at 10.00 a.m. Those who wish to participate are invited to dial in on telephone number +46 8 566 426 95. The presentation will be in English. Make sure that you are connected to the conference by dialing in and register a few minutes before the conference begins. An audio recording of the conference call will be published on www.cloetta.com. This information is information that Cloetta AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 24 August 2016 at 08.00 a.m. CET.

WntResearch announces organizational changes

By the instalment of the position as Chief Technical Officer and by the recruitment of Dennis Henriksen, the company strengthens its in-house competence and resources within the areas of regulatory affairs, clinical trials, production planning and intellectual property. Dennis Henriksen (b. 1962), M.Sc. in chemical engineering from the Technical University of Copenhagen and Ph.D. in bioorganic chemistry from the University of Copenhagen, has held leading positions in biotech companies for more than 20 years. He has great experience in the processes of research, development, registration and commercialization of pharmaceuticals and has, among other positions in the past, worked as VP for BioNebraska Inc in the United States, where he was responsible for the company’s R&D. Dennis Henriksen will take up his new position with immediate effect. “We are happy to welcome Dennis Henriksen to WntResearch. His experience and competence will strengthen the company in the preparations for the coming phase 2-study of the drug candidate Foxy-5 and in the continuing preclinical work with the drug candidate Box-5,” says Henrik Lawaetz, CEO, WntResearch. Furthermore, WntResearch announces that Chief Medical Officer Nils Brünner has declared that he will be leaving the company by the end of 2016. Nils Brünner will turn 65 in the beginning of 2017 and with the increased workload that is associated with the preparations and implementation of the planned phase 2-study of the drug candidate Foxy-5, the company and Nils have jointly determined to start the process of finding a successor. Nils Brünner has been active in WntResearch since 2008 and has played a key role in the company’s development. He will be proposed as a new member of the company’s Board of Directors. For further information contact: Henrik Lawaetz, CEOE-mail: hl@wntresearch.comTelephone: +46 72 702 4694 About WntResearch WntResearch is developing a new type of cancer treatment based on pioneering research, which shows that the endogenous protein Wnt-5a plays a crucial role for tumour cells’ ability to relocate and spread inside the body. Most patients that die of cancer do so not due to the primary tumour, but due to metastasises and the need for a specific treatment to counteract metastasis is therefore in high demand. WntResearch’s most advanced drug candidate Foxy-5 has in preclinical tests been shown to reduce tumour cells’ mobility and thereby counteract the occurrence of metastasis. The results from a completed phase 1-study show a favourable security profile and pharmacokinetics as well as early indications of biological activity. A phase 1b-study is currently ongoing in patients with cancer in colon, prostate and breast. WntResearch is a public company listed at AktieTorget in Stockholm, Sweden. For further information: www.wntresearch.com  

Immunovia Half-year report 2016

“Immunovia reached several important milestones in the first six months of 2016. Good results were obtained in the American pancreas study that was carried out in collabo­ration with Knight Cancer Institute. Presentations made at the key global conferences concerning pancreatic cancer were very well received. A specially strong Scientific Advisory Board has been recruited, and involvement from the patient organization has increased. Furthermore, several significant agreements were signed with important cancer centres. The market introduction of IMMray™ PanCan –d, Immunovia’s diagnosis test for early detection of pancreatic cancer, is expected to begin in 2017 and then generate income from the hereditary risk groups in 2018. It is planned to start pancreatic cancer tests for the diabetes group soon afterwards. In addition, it will be possible to use the test for patients seeking help with vague symptoms and where there is a need to swiftly rule out pancreatic cancer. In the second half of 2016 Immunovia’s laboratory in Lund is expected to be completed and subsequently accredited for ISO certification in 2017. CE labelling of IMMray™ PanCan –d will be concluded in 2017. It will then be possible to receive samples from all over Europe to establish early detection of pancreatic cancer, with talks already being held with several prospective customers, i.e. cancer centres and laboratories. In mid-August Immunovia announced its intention to seek a listing on Nasdaq Stockholm’s Main Market in 2017.” Key Indicators +----------------------+-----------------+-----------------+-------------+|Key   Indicators  |1 Jan-30 Jun 2016|1 Jan-30 Jun 2015| 2015 ||(SEK 000 unless | | | Full year ||otherwise stated) | | | |+----------------------+-----------------+-----------------+-------------+|Net   sales | 66| 59| 205|+----------------------+-----------------+-----------------+-------------+|Operating   earnings | -5 403| -3 836| -7 424|+----------------------+-----------------+-----------------+-------------+|Earnings   before tax | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Net earnings | -5 298| -3 807| -7 384|+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,38| -0,34| -0,65||before dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+|Earnings   per share | -0,36| -0,33| -0,62||after dilution | | | ||(SEK/share) | | | |+----------------------+-----------------+-----------------+-------------+| | | | |+----------------------+-----------------+-----------------+-------------+| | 30 Jun 2016  | 30 Jun 2015  |31   Dec 2015|+----------------------+-----------------+-----------------+-------------+|Equity   ratio, % | 93| 84| 92|+----------------------+-----------------+-----------------+-------------+|Gearing   ratio, times| 0,07| 0,19| 0,09|+----------------------+-----------------+-----------------+-------------+ Outlook*Immunovia is focused on fundamentally transforming diagnosis of complex forms of cancer and autoimmune diseases. The antibody-based platform, IMMrayTM, is the result of 15 years of research at CREATE Health – the Center for Translational Cancer Research at Lund University, Sweden. IMMray™ is a technology platform for the development of diagnostic tests and the company’s primary test, IMMray™ PanCan-d, is the first test in the world for early diagnosis of pancreatic cancer. ·  It is planned to launch IMMray™ PanCan-d on the American and European markets with sales start in 2017 to out-of-pocket customers, with revenues expected to begin in 2018. In coming years Immunovia will address a market that in total is worth around SEK 30 billion. ·  Immunovia sees great potential in the development of tests for other unsolved problems in cancer and autoimmune diseases via its IMMray™ platform. The next focus area will be tests within SLE. *No changes compared with the Financial Statement dated 24 February 2016. For further information, please contact:Mats Grahn, CEO, Immunovia ABPhone: +46 (0) 70-532 02 30E-mail: mats.grahn@immunovia.com  About ImmunoviaImmunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer.  In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source: www.immunovia.com)  Immunovia’s shares (IMMNOV) are listed on Nasdaq First North in Stockholm and Wildeco is the company’s Certified Adviser. For more information, please visit www.immunovia.com. ###

Nanologica enters into research collaboration with GSK

”We are excited about the collaboration with GSK. This is an early, but interesting project with the possibility to unlock new approaches to personalized medicine. It is a great opportunity for Nanologica to contribute to this field,” says Nanologica’s CEO Andreas Bhagwani. This paid development project is in line with Nanologica’s strategy in the business area Drug Delivery. The business model in Drug Delivery is based on having many different projects in collaboration with pharmaceutical companies to apply Nanologica’s proprietary technology to real problems of drug developers. Nanologica is increasingly seeking projects where potentially more value can be created, as this agreement illustrates. “The healthcare industry is showing growing interest in Nanologica’s technology, which for us is good evidence that we are on the right track. Our goal is to be the world-wide expert in porous silica-based materials for life science applications,” says Andreas Bhagwani. Early projects can be the starting point of long-term collaborations, but can also be limited to the initial scope and timeline. Nanologica is constantly evaluating new project proposals with the goal to identify opportunities to apply and commercialize its drug delivery systems. For further information, please contact: Andreas Bhagwani, CEO of Nanologica phone: +46 70 316 17 02 or e-mail: andreas@nanologica.com About Nanologica Nanologica develops nanoporous silica for applications in life science. The company focuses on two business areas: drug delivery and chromatography, a technology used for the separation and purification of products on the market and in development. Nanologica’s core competency is to apply its unique know-how in the field of material science for developing nanoporous silica particles with unique characteristics. Based in Södertälje, Sweden, Nanologica has 19 employees from ten nationalities of which ten are PhDs. For more information, please visit www.nanologica.com.

NeuroVive’s Chief Operating Officer Jan Nilsson leaves the company

The company is entering into a very important period and is expecting exciting developments during the fall. Over the past several months, the business strategy and organization have been re-oriented to optimize the way forward. As one consequence the position of COO is no longer required. “I have been involved in NeuroVive in different roles since 2010 and it has been fantastic to be part of the development of the company to the position it holds today. The company has a very interesting project portfolio and a strong organization. The transition to our new CEO is now concluded which makes the timing right for me to seek new challenges. I will of course follow the company’s continued development with greatest interest”, says Jan Nilsson. “Jan Nilsson has with great dedication, in combination with his vast knowledge and experience, played a key role in NeuroVive, not only as COO but also as a Director and for a period as interim CEO. Jan has been instrumental in managing the challenges faced by NeuroVive in recent years. On behalf of the entire company and its shareholders, I express our respect and appreciation for Jan and wish him all the best in his new endeavors”, says Greg Batcheller, Chairman of NeuroVive. About NeuroVive NeuroVive Pharmaceutical AB (publ) is a pioneer in mitochondrial medicine and a company committed to the discovery and development of highly targeted candidates that preserve mitochondrial integrity and function in areas of significant therapeutic need. NeuroVive's business approach is driven by value-adding partnerships with mitochondrial research institutions and commercial partners across the globe. NeuroVive's portfolio consists of two clinical projects, one in acute kidney injury (CicloMulsion®) and one in traumatic brain injury (NeuroSTAT®). The candidate drug NeuroSTAT has orphan drug designation in Europe and in the US for treatment of moderate to severe traumatic brain injury and is currently being evaluated in the CHIC study. CicloMulsion is being evaluated in an on-going study, CiPRICS, in acute kidney injury during major surgery. Furthermore, the R&D portfolio consists of two late stage discovery programs and one compound in preclinical development. NeuroVive is listed on Nasdaq Stockholm, Sweden, Small Cap, under the ticker symbol NVP. The share is also traded on the OTC Markets Group Inc market in the US. NeuroVive Pharmaceutical (OTC: NEVPF) trades on the OTCQX Best Market. For investor relations and media questions, please contact:  Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or ir@neurovive.com  NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard), Fax: +46 (0)46 888 83 48www.neurovive.com   This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CEST on August 24, 2016.  

Cantargia interim report January – June 2016

Significant events in the second quarter  · The exercise period for warrants of series TO 1 and TO 3 began on 23 March 2016 and ended on 13 April 2016. In total, 4,127,260 warrants of both series were exercised, representing around 83.5 per cent of the number of warrants issued. Through the warrants Cantargia raised approximately SEK 31.4 million before issue costs.  · During the period the Company gave investor presentations at the international BioEquity conference in Copenhagen on 10 May 2016 and at the Småbolagsdagen small cap investor event at the Sheraton Stockholm Hotel on 13 June 2016.  · The annual report for the financial year 2015 was published on 29 April 2016. The company held its Annual General Meeting on 25 May 2016 and published a report on the AGM the following day. The annual report and AGM report are available for download on the company’s website, www.cantargia.com.  · Cantargia received a Notice of Allowance from the US Patent Office for IL1RAP as target molecule for antibody-based treatment in acute lymphoblastic leukemia followed by a Notice of Allowance for IL1RAP as target molecule for antibody-based treatment in solid tumours from the same patent office. The company also received formal approval in Japan of a patent for solid tumours.  · The company announced that its CAN04 product candidate has been shown to have a high level safety in high doses – repeated treatment with up to 100 mg/kg. During the period Cantargia also decided that the company will conduct further process development studies to establish a strong foundation for long-term production and that the start of the GLP toxicity study will therefore be postponed until autumn 2016. Consequently, the start of clinical studies will also be postponed until the end of the first quarter of 2017.  · A third party filed an opposition to Cantargia’s patent in Europe for IL1RAP as a target molecule for antibody treatment and leukemia diagnostics. Cantargia will be working with its patent agents and the European Patent Office to conduct the process in a professional and correct manner. Significant events after the end of the period  · In July Cantargia announced that the US Patent Office had approved the company’s application for IL1RAP as target molecule for antibody-based treatment of solid tumours. · In August Cantargia announced that the company’s former CEO, Agneta Svedberg, has exercised 1,250 warrants of series 2011/2016. The exercise of the warrants will raise SEK 250,212.50 for Cantargia. Financial information First half (1 Jan 2016 – 30 Jun 2016)  · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -16,023 (-9,059).  · Earnings per share were approximately SEK -0.91 (-0.68).  · The equity/assets ratio was around 87 (89) per cent compared with the beginning of the year.  Second quarter (1 Apr 2016 – 30 Jun 2016) · Other operating revenue was kSEK 0 (0).  · Earnings after financial items were kSEK -7,926 (-5,432).  · Earnings per share were approximately SEK -0.45 (-0.41).  Definitions  · Earnings per share: Profit for the period divided by 17,633,134 shares as at 30 June 2016. · Equity/assets ratio: Equity divided by total capital.  · Unless otherwise indicated, figures in parentheses refer the same period in the previous year.  For further information, please contact Göran Forsberg, CEOTelephone: +46 (0)46 275 62 60E-mail: goran.forsberg@cantargia.comCertified Adviser: Sedermera Fondkommission  This constitutes information that Cantargia is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person at 8:30 (CEST) on August 24, 2016. 

HiQ ACQUIRES GREAT APES IN FINLAND – BOOSTING THE POSITION WITHIN DESIGN & DIGITAL

“This acquisition will make HiQ’s position even stronger and more relevant – it’s a great enhancement to our existing team of experts within the digital area. This will enable us to move even faster when solving our client’s challenges, all the way from idea to realisation and within the entire chain of people, technology, and business,” says Lars Stugemo, President and CEO of HiQ. Great Apes has a lot in common with HiQ and isn’t afraid to challenge existing ways of doing things. Some of the clients are Linnanmäki, Microsoft, Lidl, Amer Sports, Royal Ravintolat, Paulig Group, the Finnish Defence Forces, and Veikkaus. Great Apes is also one of the most internationally awarded digital agencies in Finland, with repeated recognition from industry-leading competitions such as The Webby Awards, Red Dot Design Awards, and Eurobest, as well as Nordic awards such as Grand One and Grafia’s Best of the Year.  “We are happy to join forces with HiQ. This will give us a lot more body and we look forward to being able to work with larger, more advanced, and game-changing projects,” says Mikko Sairio, partner and one of the three founders of Great Apes.  “I’m happy to welcome Great Apes into the HiQ team. Both HiQ and Great Apes have a strong customer base, and together we can take on even bigger assignments, using technology to create a better and more joyful world. Great Apes is a great match both competence- and culture wise. They share HiQ’s values and are a group of great people; result oriented and with a positive energy,” Stugemo concludes. In relation to the closing on 31 August, 257 832 HiQ shares will be issued, corresponding to a dilution of 0,5 %. Great Apes is expected to make a positive contribution to HiQ’s profit right from the start, and also to its earnings per share. For more information, please contact: Lars Stugemo, President and CEO of HiQ. Tel. +46 8 588 90 000 Jenny Normark Sperens, Head of Corporate Communications. Tel. +46 734 431 007

Leading construction company Sanken Overseas Pvt Ltd selects IFS Applications 9

The company chose IFS Applications to ensure access to improved management information, project profitability information, enhanced stock and employee management as well as management of subcontracting work. The IFS solution purchased by Sanken Overseas (Pvt) Ltd includes finance, supply chain, project management, and human resource capabilities and will be used by 233 employees across the organization’s geographically dispersed operations in Sri Lanka, Maldives, Seychelles, Kenya, Uganda, and Myanmar.  “Sanken is pleased to work with IFS and we look forward to deploying a fully-fledged ERP suite.” said Mr. B. B. Kulupana, Managing Director/CEO of Sanken Overseas (Pvt) Ltd. “Rapid growth of our overseas business has brought on many management challenges, which we hope the IFS solution will help us overcome and transform into an opportunity that can have a positive bearing on our margins and profitability.” Mr. Jayantha De Silva, President/ CEO of IFS Sri Lanka added, “IFS has a proven track record in the construction industry globally and we are happy to be able to embark on yet another construction implementation, this time together with a Sri Lankan company. IFS Applications is a user-friendly and easily adaptable ERP suite that I am sure will be well received by Sanken’s user base. Our experienced team of consultants and I look forward to completing yet another successful implementation.”

Nel ASA: Launches new containerised, turn-key electrolysers

(Oslo, 24 August 2016) Nel Hydrogen Electrolyser, a division of Nel ASA (Nel), today launches the new containerised NEL C-range electrolysers, thereby offering a low-cost, turn-key solution, representing the world’s smallest footprint for containerized, high capacity electrolysers. “It is with great pleasure that we announce the addition of containerised, turn-key solutions to our NEL A-range electrolysers. The existing NEL A-range are already recognised as the benchmark in energy efficiency. The containerised configuration brings a new level of innovative turn-key design, combined with unparalleled efficiency, practical design that enables quick and simple installation and the most compact solution offered in the market today”, says Jon Andre Løkke, CEO of Nel. The new configurations – Nel C-150 and Nel C-300 – are containerised and will be offered in addition to the existing industrial NEL A-range of electrolysers. The new products will have an output capacity of either 150 and 300 Nm3/hr respectively, which is equivalent to about 330 or 660 Kg/day. The standard gas output pressure will be 200 bar, which makes these products ideal for producing renewable hydrogen integrated with hydrogen fueling stations for cars, busses or other utility vehicles. “With these new products, the customer only need to push a button after connecting electricity and water. The new low-cost, turn-key solutions offer everything of our existing NEL A technology, with its proven reliability and robustness, but with added flexibility and ease-of-use. This is hydrogen production technology second to none,” says Løkke. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 Bjørn Simonsen, VP Market Development and Public Relations, + 47 97 17 98 21 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. www.nel-hydrogen.com.

NetEnt unveils hidden world of wonder with Secrets of Atlantis launch

Its subaquatic design delights include vibrant sea creatures and an alluring mermaid, on a 5-reel, 4-row, 40-line video slot platform perfected to entice players into its awe-inspiring world. Highlights, nudge wilds, colossal symbol re-spins and win both way features all add to the wondrous NetEnt graphics and ensure players an exciting gaming experience. Simon Hammon, Chief Product Officer of NetEnt, comments: “NetEnt delivers innovative game themes designed to attract players and keep them coming back for more. Now they’ll be able to get submerged in this stunning slot which once again shows why NetEnt is at the head of the market when it comes to casino games.”  View game demo (https://youtu.be/9IiPPMZFOfk) For additional information please contact:Simon Hammon, Chief Product Officer NetEnt, Phone +356 2276 8145simon.hammon@netent.comMarianne Eklund, PR Manager NetEnt, Phone +46 760 024 808marianne.eklund@netent.com  About NetEnt  NetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by their cutting-edge platform. With innovation at its core, NetEnt is committed to helping customers stay ahead of the competition. NetEnt is listed on Nasdaq Stockholm (NET-B), employs 750 people and has offices in Stockholm, Malta, Kiev, Gothenburg, New Jersey, Krakow and Gibraltar. www.netent.com 

Strong performance and profitable growth for Rovio in first half of 2016

Rovio Entertainment has grown profitably in the first half of 2016, even before the profits from the blockbuster Angry Birds Movie have hit the books. The company earned 76,4 mEUR in revenue in the first half, a 10,3 mEUR year-on-year improvement, finishing the first half with an EBIT result of 5,7 mEUR, a 15,9 mEUR improvement over the same period last year. Rovio’s games business is thriving with year-on-year revenue growth of 24 per cent. Rovio’s animation business saw the globally successful theatrical release of The Angry Birds Movie, which opened in the No. 1 position in 52 countries, including the massive Chinese and U.S. markets. The Angry Birds Movie has so far grossed more than 347 million dollars at the box office globally. The movie will open in Japan October 1. “With the excellent performance of our games portfolio and the fantastic movie, the Angry Birds brand is flying high and we are seeing positive EBIT and cash flow development, while fulfilling our mission to create world class entertainment,” says CEO Kati Levoranta. “We currently have several exciting new games and other projects in development, including new IP, and we have started planning the sequel to The Angry Birds Movie.” The Angry Birds Movie was released digitally in selected Asian markets and North America on July 29, where it quickly went to No. 1 on iTunes, followed by DVD and Blu-ray releases on August 16. The in-home release of the film in other countries and territories continues to roll out in the weeks ahead, with most of Europe seeing the in-home release in September.

ASSA ABLOY on Forbes’ list of the world’s 100 most innovative companies

ASSA ABLOY, the global leader in door opening solutions, has for the third time been ranked in Forbes’ list of the world’s most innovative companies 2016. “I’m very pleased that we have achieved such success with our R&D,” says Johan Molin, President and CEO of ASSA ABLOY. "Over the past ten years ASSA ABLOY has invested heavily in innovation, with the goal of doubling the innovation rate and the target that products launched within the past three years should account for at least 25 percent of sales. Today this target has been achieved, with a share of 31 percent of our sales from new products”. ASSA ABLOYs R&D investments have increased by 230 percent since 2005, and today the Group has more than 1 800 development engineers. ASSA ABLOYs ambition is to be the industry’s most innovative company. The full list is available at: http://www.forbes.com/innovative-companies/list/  For more information, please contact:Johan Molin, President and CEO, tel. no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel. no: +46 8 506 485 72 About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end‑user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 46,000 employees, operations in more than 70 countries and sales of SEK 68 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security.

Notices regarding Handelsbanken’s shares  in Industrivärden

Svenska Handelsbanken (publ) holds 29,367,821 Class A shares in AB Industrivärden (publ), corresponding to 6.8 per cent of Industrivärden’s share capital and 10.3 per cent of the voting rights in Industrivärden. Handelsbanken has decided to offer all such shares to institutional investors through an accelerated bookbuilding (the “Transaction”). Morgan Stanley and Handelsbanken Capital Markets are acting as Joint Bookrunners in connection with the Transaction. For further information, please contact: Ulf Riese, Chief Financial Officer, + 46 8 – 22 92 20Johan Lagerström, Global Head of Corporate Communications, + 46 8 – 701 10 00, + 46 70 – 265 80 14Mikael Hallåker, Head of Investor Relations, + 46 8 –701 29 95, + 46 70 – 266 29 95 This information is of the type that Handelsbanken is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above, on 24 August 2016 at 17.45 CET. For more information about Handelsbanken, see: www.handelsbanken.com (http://www.handelsbanken.se/)  IMPORTANT NOTICE THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL, OR SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF THE SHARES IN THE UNITED STATES. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION  WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH  THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION. IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU. IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED. IN CONNECTION WITH THE TRANSACTION, THE MANAGERS AND ANY OF THEIR AFFILIATES ACTING AS AN INVESTOR FOR THEIR OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR THEIR OWN ACCOUNT SUCH SHARES. IN ADDITION THE MANAGERS OR THEIR AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE MANAGERS (OR THEIR AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE MANAGERS DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO. NO GUARANTEE CAN BE MADE THAT ANY SECURITIES WILL BE SOLD PURSUANT TO THE TRANSACTION. THE MANAGERS ARE ACTING ON BEHALF OF HANDELSBANKEN AND NO ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE MANAGERS OR FOR PROVIDING ADVICE IN RELATION TO THE TRANSACTION.  

Nordea and DNB to combine Baltic operations

Nordea and DNB have entered into an agreement to combine their operations in Estonia, Latvia and Lithuania to create a leading main bank in the Baltics with strong Nordic roots. “Combining knowledge of the Baltic market, close cooperation with our customers and developments in digital banking, Nordea has over the years built a solid and successful bank in the Baltic region with a strong position as number three in the Baltics. Now it is time to take the next step and build for the future. Together we will have the scale, stronger geographic presence and broader product offering enabling us to become the main bank for customers in the Baltics,” says Inga Skisaker, Head of Banking Baltic Countries, Nordea. Nordea’s and DNB’s operations in the Baltics are a great match, with complementary lines of business. Nordea has built a strong position within the large corporate segment whereas DNB is strong in the SME segment. Together, the banks will also have an even larger and more competitive retail business. Furthermore, the combined bank will have a strong geographic presence, with Nordea’s strong Estonian, DNB’s strong Lithuanian and jointly strong Latvian footprints. Nordea’s and DNB’s Baltic operations have 1,300 and 1,800 employees and EUR 8 billion and EUR 5 billion in assets[1], respectively. “With over 70 branches in the Baltics, DNB have created a dynamic and customer-centric operation. Scale is key in banking today, with larger banks having more efficient use of resources. The new bank will be better equipped to counter increasing competition in the region and capitalise on scale in order to become the main bank for more businesses, customers and partners in the Baltics,” says Mats Wermelin, Head of Baltic Division, DNB. Nordea and DNB will have equal voting rights over the combined bank, while having different economic ownership levels that reflect the relative equity value of their contribution to the combined bank at the time of closing. The transaction is conditional upon regulatory approvals and conditions, and is expected to close around Q2 2017. The banks will operate independently until all necessary approvals have been received.  [1] Based on loans and receivables to the public With regard to the announcement we invite you to a press meeting. Inga Skisaker, Head of Banking Baltic Countries, Nordea and Mats Wermelin, Head of Baltic Division, DNB will participate.   Time: Thursday 25 August 11.30 CET (12.30EET). For security reasons, a valid identity card is required. To attend the press conference, please e-mail Signe Lonerte, signe.lonerte@nordea.com, +371 2911 6146.   Place: The Radisson Blu Hotel Latvija, Elizabetes 55, Riga, LatviaThe press conference will be conducted in English.  For further information:   Nordea:Signe Lonerte, Head of Communication Baltic Countries, Nordea, +371 29 11 61 46, signe.lonerte@nordea.comMagnus Nelin, Chief Press Officer, Sweden, Nordea, +46 721 45 26 40, magnus.nelin@nordea.com DNB:Thomas Midteide, Group Executive Vice President, Corporate Communications, DNB, +47 962 32 017, thomas.midteide@dnb.no   About Nordea Nordea is among the ten largest universal banks in Europe in terms of total market capitalisation and has around 11 million customers, 30,000 employees and approximately 600 branch office locations. The Nordea share is listed on the Nasdaq Stockholm, Nasdaq Helsinki and Nasdaq Copenhagen exchanges. We have a broad expertise across the wide range of products, services and solutions that we provide within banking, asset management and insurance. In Nordea we build trusted relationships through our strong engagement with both customers and society. About DNB  DNB is Norway's largest financial services group and one of the largest in the Nordic region in terms of market capitalization. The Group offers a full range of financial services, including loans, savings, advisory services, insurance and pension products for retail and corporate customers. DNB is a major operator in a number of industries, for which we also have a Nordic or international strategy. DNB is one of the world’s leading shipping banks and has a strong position in the energy sector, and the fisheries and seafood industry.

Nel ASA: Second quarter 2016 results

(Oslo, 25 August 2016) Nel ASA (Nel) reported revenues in the second quarter of NOK 13.5 million, reflecting the fluctuating nature of Nel’s project business, as well as initiation of certain projects being postponed to the second half of 2016. The underlying project pipeline is strong and Nel has submitted a proposal for the fourth quarter allocation of the governmental hydrogen program in California. ”The second quarter was a busy period for Nel. We have introduced the next generation fueling station, the CAR-200, with orders already being placed by leading European customers. We also recently announced the new Nel C-range containerised turn-key electrolyser solution, setting the benchmark for hydrogen production efficiency and footprint. The establishment of Nel Hydrogen Solutions business area enhances market opportunities across the group, initiatives are already yielding results, and Nel is positioned at the forefront of a rapidly growing hydrogen industry”, says Jon Andrè Løkke, Chief Executive Officer of Nel.   In the second quarter of 2016, Nel reported revenues of NOK 13.5 million (Q2’15: MNOK 16.0), reflecting the fluctuating nature of the company’s project business, as well as initiation of certain projects being postponed to the second half of 2016. EBITDA ended at NOK -14.0 million (-5.3), impacted by the high activity level within business development in new markets, investments, and preparation for production ramp-up. Nel’s cash balance at the end of the second quarter was NOK 265.9 million, up from NOK 152.2 million at the end of the second quarter in 2015.   “Nel is a pure play hydrogen company with market leading technology, a strong management team, a solid balance sheet, and is positioned to play a leading role in a fast-moving industry. The underlying project development pipeline is strong and the company experiences a high activity level in ongoing tender processes,” says Løkke. In California, the Energy Commission has doubled the Governmental Grant Opportunities (GFO) hydrogen program to USD 33 million, with a target to reach 100 hydrogen fueling stations by 2020. ”Nel is taking both a direct and an indirect approach to the important California market, leveraging on delivering leading hydrogen technology. California represents an important opportunity for Nel as 33 percent of the hydrogen must be renewable, today hardly any hydrogen is made from renewables. We have submitted our California funding proposal and look forward to the governmental allocation that should take place during the fourth quarter of 2016, ” says Jon André Løkke. The presentation will be broadcasted live at www.nel-hydrogen.com/webcast and can also be viewed at http://webtv.hegnar.no/presentation.php?webcastId=36902334 The second quarter 2016 report and presentation will be made available through www.newsweb.no and www.nel-hydrogen.com. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 90 74 49 49 About Nel Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. www.nel-hydrogen.com

NetEnt launches games with The Rank Group Plc

The Rank Group Plc is one of the largest gaming companies in Europe with a strong market presence in the UK and with well-known brands such as Grosvenor Casinos (www.grosvenorcasinos.com) and Mecca (www.meccabingo.com). For more information about the agreement with Rank Group, please see the press release from June 2016: https://www.netent.com/en/netent-signs-customer-agreement-with-the-rank-group-plc/ For additional information please contact:Enrico Bradamante, MD of NetEnt Malta Ltd and Chief of European Market Operations Phone: +356 79 676 868enrico.bradamante@netent.com Roland Glasfors, Investor Relations, NetEnt AB (publ)Phone +46 760 024 863roland.glasfors@netent.com This information is information that NetEnt AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CET on August 25, 2016. About NetEntNetEnt AB (publ) is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ Stockholm (NET–B) and employs 800 people in Stockholm, Malta, Kiev, Krakow, Gothenburg, Gibraltar and New Jersey. www.netent.com

Handelsbanken has divested all of its A-shares in Industrivärden

Svenska Handelsbanken AB (publ) (“Handelsbanken”) has today sold all of its A-shares, 29,367,821 Class A shares in AB Industrivärden (publ) (“Industrivärden”), corresponding to 6.8 per cent of Industrivärden’s share capital and 10.3 per cent of the voting rights. The price is set to SEK 153.25 per share (the “Transaction”). The shares have been acquired by Swedish and international institutional investors. The Transaction will result in a capital gain for Handelsbanken of approximately SEK 750 million, which will have a positive impact on Handelsbanken’s earnings in the third quarter of 2016. The divestment will not result in any increase in Handelsbanken’s equity, as the shares were recognized as an available-for-sale asset at market value in the bank’s accounts. As a result of the Transaction, Handelsbanken’s risk exposure amount will decrease and the expected positive impact on Handelsbanken’s common equity tier 1 ratio is estimated at approximately 0.6 percentage points. Morgan Stanley and Handelsbanken Capital Markets acted as Joint Bookrunners in the Transaction. For further information, please contact: Ulf Riese, Chief Financial Officer, + 46 8 – 22 92 20Mikael Hallåker, Head of Investor Relations, + 46 8 – 701 29 95, + 46 70 – 266 29 95Johan Wallqvist, Head of Media Relations, +46 8 – 701 10 00, + 46 72 – 206 34 50 This information is of the type that Handelsbanken is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above, on 25 August 2016 at 07.30 a.m. CET. For more information about Handelsbanken, see: www.handelsbanken.com (http://www.handelsbanken.se/)  IMPORTANT NOTICE   THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL, OR SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") AND MAY NOT BE SOLD IN THE UNITED STATES ABSENT REGISTRATION WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL NOT BE A PUBLIC OFFERING OF THE SHARES IN THE UNITED STATES. THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES OR INVESTMENTS FOR SALE OR A SOLICITATION OF AN OFFER TO BUY SECURITIES OR INVESTMENTS IN ANY JURISDICTION WHERE SUCH OFFER OR SOLICITATION  WOULD BE UNLAWFUL. NO ACTION HAS BEEN TAKEN THAT WOULD PERMIT AN OFFERING OF THE SECURITIES OR POSSESSION OR DISTRIBUTION OF THIS ANNOUNCEMENT IN ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS INTO WHOSE POSSESSION THIS ANNOUNCEMENT COMES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY SUCH RESTRICTIONS. ANY FAILURE TO COMPLY WITH  THESE RESTRICTIONS MAY CONSTITUTE A VIOLATION OF THE SECURITIES LAWS OF ANY SUCH JURISDICTION. IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA ("EEA") WHICH HAVE IMPLEMENTED THE PROSPECTUS DIRECTIVE (EACH, A "RELEVANT MEMBER STATE"), THIS ANNOUNCEMENT AND ANY OFFER IF MADE SUBSEQUENTLY IS DIRECTED EXCLUSIVELY AT PERSONS WHO ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF THE PROSPECTUS DIRECTIVE ("QUALIFIED INVESTORS"). FOR THESE PURPOSES, THE EXPRESSION "PROSPECTUS DIRECTIVE" MEANS DIRECTIVE 2003/71/EC (AND AMENDMENTS THERETO, INCLUDING THE 2010 PD AMENDING DIRECTIVE, TO THE EXTENT IMPLEMENTED IN A RELEVANT MEMBER STATE), AND INCLUDES ANY RELEVANT IMPLEMENTING MEASURE IN THE RELEVANT MEMBER STATE AND THE EXPRESSION "2010 PD AMENDING DIRECTIVE" MEANS DIRECTIVE 2010/73/EU. IN THE UNITED KINGDOM THIS ANNOUNCEMENT IS DIRECTED EXCLUSIVELY AT QUALIFIED INVESTORS (I) WHO HAVE PROFESSIONAL EXPERIENCE IN MATTERS RELATING TO INVESTMENTS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE "ORDER") OR (II) WHO FALL WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, AND (III) TO WHOM IT MAY OTHERWISE LAWFULLY BE COMMUNICATED. IN CONNECTION WITH THE TRANSACTION, THE MANAGERS AND ANY OF THEIR AFFILIATES ACTING AS AN INVESTOR FOR THEIR OWN ACCOUNT MAY TAKE UP AS A PRINCIPAL POSITION ANY SHARES AND IN THAT CAPACITY MAY RETAIN, PURCHASE OR SELL FOR THEIR OWN ACCOUNT SUCH SHARES. IN ADDITION THE MANAGERS OR THEIR AFFILIATES MAY ENTER INTO FINANCING ARRANGEMENTS AND SWAPS WITH INVESTORS IN CONNECTION WITH WHICH THE MANAGERS (OR THEIR AFFILIATES) MAY FROM TIME TO TIME ACQUIRE, HOLD OR DISPOSE OF SHARES. THE MANAGERS DO NOT INTEND TO DISCLOSE THE EXTENT OF ANY SUCH INVESTMENT OR TRANSACTIONS OTHERWISE THAN IN ACCORDANCE WITH ANY LEGAL OR REGULATORY OBLIGATION TO DO SO. NO GUARANTEE CAN BE MADE THAT ANY SECURITIES WILL BE SOLD PURSUANT TO THE TRANSACTION. THE MANAGERS ARE ACTING ON BEHALF OF HANDELSBANKEN AND NO ONE ELSE IN CONNECTION WITH THE TRANSACTION AND WILL NOT BE RESPONSIBLE TO ANY OTHER PERSON FOR PROVIDING THE PROTECTIONS AFFORDED TO CLIENTS OF THE MANAGERS OR FOR PROVIDING ADVICE IN RELATION TO THE TRANSACTION.   Forward-Looking Statements Matters discussed in this communication may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intend,” “may,” “plan,” “estimate,” “will,” “should,” “could,” “aim” or “might,” or, in each case, their negative, or similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurances that they will materialize or prove to be correct. Because these statements are based on assumptions or estimates and are subject to risks and uncertainties, the actual results or outcome could differ materially from those set out in the forward-looking statements as a result of many factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The Company does not guarantee that the assumptions underlying the forward-looking statements in this presentation are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or any obligation to update or revise the statements in this presentation to reflect subsequent events. Undue reliance should not be placed on the forward-looking statements in this document. The information, opinions and forward-looking statements contained in this communication speak only as at its date, and are subject to change without notice. The Company does not undertake any obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this communication. 

SAF-HOLLAND withdraws all-cash offer for Haldex AB

Luxembourg, 25 August 2016 - SAF-HOLLAND GmbH (“SAF-HOLLAND”), a wholly-owned subsidiary of SAF-HOLLAND S.A., announced an all-cash offer for Haldex AB (publ) (“Haldex”) in the amount of SEK 94.42 per Haldex share on 14 July 2016 (the “Offer”). On 11 August 2016, SAF-HOLLAND gave notice, in light of a higher offer announced by another bidder on 4 August 2016, that the Offer price would not be increased. The acceptance period for the Offer ended on 24 August 2016. As of the end of the acceptance period, 199,461 Haldex shares, representing 0.45 per cent of the outstanding shares and votes, had been tendered. Completion of the Offer was, among other things, conditional upon the offer being accepted by Haldex’ shareholders to such an extent that SAF-HOLLAND would become the owner of shares representing more than 90 per cent of the outstanding shares in Haldex. This condition has not been satisfied. Thus, SAF-HOLLAND has decided to withdraw the Offer. Accordingly, the shares tendered will not be acquired by SAF-HOLLAND and will remain in the respective holders’ ownership without any action needed on the part of the shareholder. As previously communicated, SAF-HOLLAND is holding 1,590,000 shares in Haldex, representing 3.6 per cent of the outstanding shares and votes, following purchases prior to the Offer announcement. SAF-HOLLAND remains commited to generating value for all its stakeholders and delivering on its Strategy 2020. The Group sees itself very well positioned as it operates on the basis of a strong business model and long-standing relationships to its customers. Furthermore, it has a number of strategic initiatives underway to further expand its market presence and generate profitable growth. SAF-HOLLAND Profile:SAF-HOLLAND S.A., located in Luxembourg, is the largest independent listed supplier to the commercial vehicle market in Europe. With sales of approximately EUR 1,060 million in 2015 and more than 3,100 employees, the company is one of the world’s leading manufacturers and suppliers of chassis-related systems and components primarily for trailers, trucks, buses, and recreational vehicles. The product range comprises axle and suspension systems, fifth wheels, kingpins, and landing gear and is marketed under the brands SAF, HOLLAND, and Neway. SAF-HOLLAND sells its products to Original Equipment Manufacturers (OEMs) on six continents. The Group's Aftermarket business sells spare parts to the service networks of Original Equipment Suppliers (OES), as well as to end customers and service centers through its extensive global network of parts distribution centers. SAF-HOLLAND is one of the few suppliers in the truck and trailer industry that is internationally positioned in almost all markets worldwide.  SAF-HOLLAND contact for investors/analystsStephan HaasTelephone: +49 (0)6095 301 617Email: stephan.haas@safholland.de Christina HüttnerTelephone: +49 (0)6095 301 255Email: christina.huettner@safholland.de  Contact for Swedish media and investorsNarvaFrank BaggeTelephone: +46 (0) 76 006 24 76Email: frank.bagge@narva.se (hans.westerberg@narva.se)  Olof EhrsTelephone: +46 (0) 70 481 72 34Email: olof.ehrs@narva.se Contact for German media and additional contact for investorsFTI Consulting Carolin AmannTel: +49 (0) 69 92037 132Email: carolin.amann@fticonsulting.com  Anja MeuselTel: +49 (0) 69 92037 120Email: anja.meusel@fticonsulting.com  This press release was submitted for publication on 25 August 2016 at 7:30 (CEST). Important noticeThis is a translation of the original Swedish language press release. In the event of discrepancies, the original Swedish wording shall prevail. The distribution of this press release and any related offer documentation in certain jurisdictions may be restricted or affected by the laws of such jurisdictions. Accordingly, copies of this communication are not being, and must not be, mailed or otherwise forwarded, distributed or sent in, into or from any such jurisdiction. Therefore, persons who receive this communication (including, without limitation, nominees, trustees and custodians) and are subject to the laws of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, SAF-HOLLAND disclaims any responsibility or liability for the violations of any such restrictions by any person. The offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or any other jurisdiction in which the making of the offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of SAF-HOLLAND and Haldex. Any such forward-looking statements speak only as of the date on which they are made and SAF-HOLLAND has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations. Notice to shareholders in the United StatesThe offer is being made for the securities of a Swedish company and is subject to Swedish disclosure requirements, which are different from those in the United States. Also, the settlement procedure with respect to the offer will comply with Swedish law, which differs from US domestic tender procedures in certain material respects, particularly with regard to the date of payment of consideration. The offer is being made in reliance upon exemptions afforded by Rule 14d-1(c) under the US Securities Exchange Act of 1934. It may be difficult for investors in the United States to enforce their rights and any claim they may have arising under federal securities laws since the companies are located in a non-US jurisdiction, and some or all of their officers may be residents of non-US jurisdictions. Such US investors may not be able to sue a non-US company or its officers or directors in a non-US court for violations of the US securities laws. It may be difficult to compel a non-US company and its affiliates to subject themselves to a US court’s judgment. In accordance with normal Swedish market practice, SAF-HOLLAND, its nominees or its brokers (acting as agents) may from time to time make certain acquisitions or arrangements to acquire Haldex shares outside the United States, other than pursuant to the offer, before the offer commences and through the expiration of the offer. These acquisitions may occur either in the open market at prevailing prices or in private transactions at negotiated prices. Any information about such acquisitions will be disclosed to the extent required by Swedish law or rules or regulations. The offer in the United States is being made solely by SAF-HOLLAND and not by any other person.  

Raysearch Laboratories AB (publ) Interim report January 1 – June 30, 2016

“Revenues from RayStation® rose 100 percent to SEK 107.8 M (53.9) and prospects are favorable for the rest of the year.The development of RayCare® is progressing as planned and we will demonstrate the system at the 2016 ASTRO radiation therapy conference in Boston at the end of September,” says Johan Löf, President and CEO of RaySearch. SECOND QUARTER (APRIL - JUNE 2016) · Net sales SEK 119.0 M (77.3), of which RayStation SEK 107.8 M (53.9) · Profit after tax SEK 28.8 M (loss: 2.6) and earnings per share were SEK 0.84 (loss: 0.08) · Operating profit SEK 37.5 M (loss: 2.1) · Cash flow negative SEK 21.0 M (neg: 10.1) · Order intake excl. service agreements SEK 129.1 M (72.0), of which RayStation SEK 120.8 M (55.3) · Order backlog for RayStation was SEK 65.2 M (40.2) at the end of the period HALF-YEAR (JANUARY - JUNE, 2016) · Net sales SEK 214.4 M (165.1), of which RayStation SEK 188.6 M (116.6) · Profit after tax SEK 46.6 M (22.4), and earnings per share SEK 1.36 (0.65) · Operating profit SEK 60.8 M (31.0) · Cash flow negative SEK 26.3 M (neg: 2.3) · Order intake excluding service agreements SEK 211.0 M (158.3), of which RayStation SEK 193.4 M (124.4) SIGNIFICANT EVENTS DURING THE SECOND QUARTER · RaySearch has continued to secure more major orders from some of the world’s largest and most respected cancer clinics, including the University of California San Francisco and the Miami Cancer Institute in the US, a number of proton clinics in Japan, and the Holland Particle Therapy Centre in the Netherlands. SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD · Victoria Sörving, General Counsel, has decided to leave the company effective September. ABOUT RAYSEARCH RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch develops and markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is currently used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003. More information about RaySearch is available at www.raysearchlabs.com. FOR FURTHER INFORMATION, PLEASE CONTACT: Johan Löf, Tel: +46 8 E-mail: johan.lof@raysearchlabs.com President and 510 530 00 CEO  Peter Thysell, Tel: +46 E-mail: peter.thysell@raysearchlabs.com CFO  70 661 05 59

Recipharm increases lyophilisation capacity in Italy

The investment forms part of Recipharm’s strategy to become a leading lyophilisation provider, and is in addition to the ongoing investment at Recipharm in Wasserburg, Germany, where a further €32 million is currently being spent to increase capacity. Specialising in aseptic manufacturing and filling of parenterals, Recipharm in Masate, located close to Milan, offers lyophilisation capabilities in both vials and ampoules. The investment will see the introduction of a new lyophiliser for vials, bringing the total number of machines from five to six and increasing the facility’s capacity by approximately 20 per cent. The new machine will allow the CDMO to support more drug developers with their stability challenges and meet growing demand for its lyophilisation services, particularly in Europe, China and Japan. Commenting on the investment, General Manager Giorgio Bruno said: “We are experiencing greater demand for lyophilisation capabilities from our customers, ranging from some of the largest pharmaceutical companies to small and mid-sized firms. As we continue to receive more requests from existing customers and new enquiries from drug developers in new territories, we needed to increase our capacity”. Contact informationGiorgio Bruno, General Manager, giorgio.bruno@recipharm.com, +39 3358100229Kjell Johansson, President Manufacturing Services Europe, kjell.johansson@recipharm.com, + 46 739 622620 For media enquiries, please contact Lindsay Baldry at ramarketing: lindsay@ramarketingpr.com,+ 44 (0)191 222 1242, ramarketingpr.com, Twitter: @ramarketingpr, Facebook: /ramarketingpr,Linkedin: /ramarketing About RecipharmRecipharm is a leading CDMO (Contract Development and Manufacturing Organisation) in the pharmaceutical industry employing some 3,500 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from Big Pharma to smaller research- and development companies. Recipharm’s turnover is approximately SEK 5.0 billion and the Company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Jordbro, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.For more information on Recipharm and its services, please visit www.recipharm.com

Senzime in collaboration with Örebro University

The so-called inflammasome is a relatively newly discovered protein complex, which has a key role in the immune system, is a cellular engine that helps the body's immune system to detect various substances that can be a threat and protect the body against infections. One in three people have inflammasomes that are easily triggered. This risk factor, which drives an inflammatory process, can affect some people when other are not; their immune system overreacts and become harmful. The collaboration with Örebro University seeks to explain how inflammasomes work in different medical situations, with different stimuli and in different individuals. Researchers at Örebro University have received SEK 11 million from the KK Foundation, and together with four companies, including Senzime; the aim is to explain why the immune system reacts differently in different individuals. For Senzime this is an important partnership in which the company will access researchers and Örebro University network and be a part of leading research in inflammation in order to understand why some individuals are more likely to become ill after an operation and also to present new clinical data. "Senzime will deliver products to the healthcare market that contribute to improved patient safety and reduced health care costs. The collaboration with Örebro University aims to do achieve this and we will, with resources, instruments, consumables and microdialysis probes, help to increase knowledge of inflammasomes, thereby early identifying patients with higher risk of becoming ill after an operation, during an infection or because of polluted air, "says Lena Söderström, CEO of Senzime AB. For further information, please contact: Lena Söderström, CEO of Senzime ABTel: +46-708-16 39 12, email: lena.soderstrom@senzime.com TO THE EDITORSAbout Senzime Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of $10 billion. The company's shares are listed on AktieTorget (ATORG: SEZI) www.senzime.com 

Environmental pioneer Viking Grace marks 1,000 LNG bunkerings

One thousand bunkerings via the M/S Seagas The M/S Seagas, which was specially built for ship-to-ship refuelling, has performed its 1,000th LNG bunkering of the Viking Grace since that vessel was placed in service in January 2013. The Seagas supplies the Viking Grace with about 60 tonnes of LNG while the vessel is docked in the morning at Stadsgården in central Stockholm. The Seagas is the first vessel of its kind in the world and is classified according to the same regulations as for ocean-going LNG tankers. Viking Line’s wish was for bunkering to occur as quickly as possible, with no interruptions, with assured deliveries and without affecting cargo handling on the quay. With its safe LNG bunker solution using the Seagas, AGA could meet Viking Line’s needs. The safety aspect was also extremely important in this context. “We are really pleased about having used LNG to fuel the M/S Viking Grace”, says Jan Hanses, President and CEO of Viking Line Abp. “Both the technical solution developed by AGA and the vessel’s operation have outperformed expectations, and it is gratifying to note the major benefits for the workplace along with the environmental gains that running on LNG provides.”    “We are obviously delighted with the positive response we have had from Viking Line regarding the Seagas and our bunkering solution”, says Jonas Åkermark, who is in charge of the LNG marine market at AGA Gas AB. “There is still heavy interest in the Seagas, our ship-to-ship bunkering solution and LNG as a marine fuel both in Sweden and internationally. We have a well-functioning infrastructure solution in place in Stockholm and the possibility of bunkering more vessels.” Positive response In February 2012, Viking Line signed an agreement with AGA Gas AB for the delivery of liquefied natural gas (LNG) for its newly ordered passenger vessel the Viking Grace. With its strong environmental profile, the ship was a trailblazer in the marine industry, going into service less than a year later, in January 2013. There were many unanswered questions, including how the gas would actually be supplied to the vessel and the attitude of customers towards what, for them, was a new type of fuel. Among the steps it took to ensure it was well prepared, Viking Line put together factsheets about the properties of the gas. The company expected some degree of scepticism, but in retrospect the response was incredibly positive. Viking Line received a very favourable response to the fuel alternative it had chosen and for the environmental values that the Viking Grace represented. International attention also exceeded all expectations. For further information, please contact: Johanna Boijer-Svahnström, Vice President Corporate Communications, johanna.boijer@vikingline.com, +358 18 270 00 Kari Granberg, Project Head, Marine Operations, kari.granberg@vikingline.com, + 358 18 270 00 Christa Grönlund, Communications Manager, Finland, christa.gronlund@vikingline.com, +358 9 123 5242 Eleonora Hansi, Communications Manager, Sweden, eleonora.hansi@vikingline.com, 08-452 41 41 Jonas Åkermark, LNG Marine - Sales and Business Development Manager, AGA Gas ABjonas.akermark@se.aga.com ,+ 46-8-731 18 44  Film in swedish: https://youtu.be/YojYr1pXTpI

New Book By Saab: A Journey Of Change In The Aircraft Industry

During the years 2000 to 2015, Saab systematically and increasingly utilised change management to adapt the company to rapid and fundamental changes. At the same time, the company also worked to ensure its survival in an increasingly globalised and competitive market. Today, Saab is a world-leading manufacturer of advanced fighter aircraft systems and the new book aims to illustrate some important keys to success. “With the Gripen programme Saab has developed a unique capacity to develop, produce and export highly competitive fighter aircraft at the very forefront of technology. With this book we wish to inspire others to initiate and conduct change management, regardless of organisational type“, says Ulf Nilsson, head of Saab business area Aeronautics. The new book was launched at a press event in Linköping on Thursday 25 August. Please click here (http://www.saabaircraftindustry.com) to access the book, which is available digitally only in both English and Swedish. For further information, please contact:Saab Press Centre,+46 (0)734 180 018,presscentre@saabgroup.com www.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saab (http://www.saabgroup.com/YouTube) Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Finland’s largest media companies to launch a shared Automated Guaranteed marketplace

Press release 25 August 2016 at 10 a.m. FINLAND’S LARGEST MEDIA COMPANIES TO LAUNCH A SHARED AUTOMATED GUARANTEED MARKETPLACE Ten Finnish media companies (Sanoma Corporation, Alma Media Corporation, Otavamedia Ltd, Aller Media Oy, A-lehdet Oy, MTV Oy, KSF Media Ab, Kaleva365 Oy, Improve Media Oy and Keskisuomalainen Oyj) will launch a shared Automated Guaranteed marketplace in autumn 2016. The marketplace makes it easier and faster for media agencies to plan and buy digital advertising. The marketplace covers desktop, mobile and video advertising products. - It’s great to see Finnish media companies joining forces and launching a shared tool for Automated Guaranteed buying. For quite some time now, there’s been a need for a controlled and fast process for reserving and buying digital advertising. We and other media agencies are eagerly looking forward to using this new tool. It represents a positive step forward that we have been hoping to see, says Antti Kallio, Director of Technology at media agency Dagmar. Digital advertising can be bought in an automated manner either as an Automated Guaranteed transaction or by Real Time Bidding. Buying guaranteed campaigns has been a largely manual process. The Automated Guaranteed solution automates the buying process, thereby significantly reducing the work phases involved in booking campaigns with guaranteed impressions. - Our goal is to make it easier and more efficient to buy media space. Many of the tools are still in the development phase globally, so it is great to see Finnish media companies and agencies promoting progress in automated buying, says Johanna Vartiainen, Director of Digital Ad Operations and Development at Alma Media. - We are pleased to work together to introduce a tool here in Finland that ensures the competitiveness of Finnish media in the digital market, adds Hans Edin, Chief Commercial Officer at Sanoma Media Finland. The media companies have selected Adform A/S, a company that specialises in digital advertising solutions, as their shared system provider. Adform has operated in Finland since 2012 and it provides a comprehensive range of online advertising tools for advertising buyers as well as sellers. Adform’s development resources provide a strong foundation for the development of the new system and its launch in the media market. The shared Automated Guaranteed marketplace will simplify advertising buying processes by making it possible to buy digital advertising products from Finland’s largest media companies through a single tool. The service allows buyers to select suitable media and products, check the availability of impressions, negotiate prices, reserve ad placements and submit campaign materials directly to the publishers’ ad servers. Buyers will also be able to monitor the progress of their campaigns through the service. In 2015, 85 per cent of digital advertising campaigns in Finland were bought with traditional guaranteed impressions. In recent years, digital advertising as a whole has quickly risen to become the largest category of advertising. Investments in digital advertising exceeded the print advertising volume for the first time in the first quarter of 2016. In 2015, digital advertising spending in Finland amounted to MEUR 286.1. For more information, please contact: Alma Media, Johanna Vartiainen, tel. +358 50 514 1952Sanoma Media Finland, Timo Rinne, tel. +358 40 571 3634

SCAN BIDCO A/S SUCCESSFULLY COMPLETES SUBSEQUENT ISSUE OF BONDS

Scan Bidco A/S, the parent company of Scan Global Logistics Holding ApS (“Scan Global Logistics” or the “Group”), has successfully completed a subsequent issue of bonds (the “Subsequent Issue”) under the framework of its maximum USD 250 million senior secured dual-tranche bond loan with ISIN NO0010768062 respectively NO0010768070 (the “Bonds”). Following the Subsequent Issue, the outstanding nominal amount under the Bonds will be USD 100 million and DKK 500 million, respectively. The proceeds from the Subsequent Issue will be used to support the bringing together of Scan Global Logistics and TransGroup, its longstanding partner in the United States and a shareholder of the Group, under common ownership.     The transaction was well received by the market, with participation from institutional and private wealth accounts from throughout the Nordics and Continental Europe. Altogether, approximately 50 investors participated in the oversubscribed issue, which was priced at par. Pareto Securities AB acted as Sole Bookrunner in connection with the bond issue. For more information, please contact:Jesper Nielsen, Group CEO, Scan Global LogisticsTel: +45 3248 0004, email: jnie@scangl.comMarkus Wirenhammar, Head of Debt Capital Markets, Pareto Securities ABTel: +46 70 872 5186, email: mw@paretosec.com  About Scan Global LogisticsScan Global Logistics is a Nordic based full-service global freight forwarding provider with nearly 800 employees working out of 42 offices in 19 countries, specialized in complex logistics solutions. SGL offers customers a wide range of global transportation and logistics supply chain solutions with a complete coverage on air, sea and overland transportation.

Zinzino launches new product segment: Zinzino Skin Care

Zinzino AB (publ), one of the world's leading direct sales companies within the health products sector, will now launch Zinzino Skin Care as a completely new product segment. The first product launched under the new banner is Skin Serum – 24 hour youth formula. The launch will take place immediately in August on the US market and will be introduced to Europe in October. Skin Serum has been developed by Zinzino and is produced in Zinzino's own production facility, Faun Pharma located just outside of Oslo in Norway. In the USA, the facial skincare product segment is estimated to report turnover of around USD 5.5 billion in 2016. The European market at least matches that in the US. Skin Serum has become a highly attractive product within the Skin Care segment and Zinzino has identified substantial potential for its new product, which will contribute strongly to the company achieving its growth targets and ensuring customer satisfaction.   Zinzino believes that product development is one of the key success factors for increased growth and expansion. Both new products and the development of existing products represent opportunities for enhanced growth, and July saw us begin sales in 19 new territories, meaning the company is now recording sales throughout the entire EU.  – Thanks to our in-house research and development and the fact that we ourselves produce our products, we can be sure that we maintain an extremely high level of quality from start to finish, while simultaneously keeping production costs as low as possible. We are now represented in 33 countries, with a total population of almost one billion. Our potential market is enormous, and with the products we now have in our portfolio, I have full confidence that we will achieve our goals. Our customers and partners must have faith that there is no let up in our own development and be certain that we are offering the best possible products, says Dag Bergheim Pettersen, CEO of Zinzino.   Zinzino Skin Serum is an active formula which gives skin a youthful appearance. Zinzino Skin Serum moisturises and softens the skin, boosting elasticity and rejuvenation. It eliminates fine lines and reduces wrinkles. The serum has both short-term and long-term beneficial effects and is applied under day and night cream. In addition, Zinzino Skin Serum has a neutral scent meaning that it does not compete with other scented products.  For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579Certified Adviser: Erik Penser Bank                         www.zinzino.se The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016. Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company's values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health's products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

Q-Free Open Roads contracted for ATMS Service and Maintenance contract with WVDOH

25 August 2016 Chesapeake, VA— The West Virginia Division of Highways has contracted Q-Free Open Roads, Chesapeake (Q-Free OR), the leading provider of innovative Intelligent Transportation Systems (ITS), for a $1.4 million maintenance contract to maintain and enhance OpenTMS v.8, the WVDOH Advanced Transportation Management System (ATMS). In 2008, Q-Free OR designed and deployed the WVDOH statewide ATMS solution – OpenTMS, the most fully-featured and easy-to-use off-the-shelf ATMS solution on the market, enabling intelligent and automated transportation operations. The collaborative effort between Q-Free OR and WVDOH has resulted in West Virginia becoming a national leader in ITS.  New initiatives since 2008 have included · Statewide 511 Travelers Information System that includes a “Know Before You Go” travelers information web site, www.wv511.org, a cell phone app, “Drive Safe” and an Interactive Voice Response (IVR) telephone system. · Twenty-four 911 CAD Integrations providing “real time” 911 Center highway related incident information to the WVDOH Transportation Management Center (TMC). · Video Analytics System providing 24/7 automatic incident detection, working in the background to assist TMC Operators. · Truck Parking Guidance System supplying the trucking industry information on available truck parking spaces in rest areas. · Automated Incident Management System presenting TMC operators with recommended incident response plans per a “Drools Guvnor ‘Rules Based’ Engine” specifically written to follow WVDOH standard procedures. Q-Free OR is a leading supplier of Intelligent Transportation Systems products and services. The Q-Free Group has approximately 470 employees with offices in 20 countries and presence on all continents. The Q-Free head office is in Trondheim, Norway. Q-Free is listed on Oslo Stock Exchange under the ticker QFR. Further Q-Free information is available at www.q-free.com . Contact Details Q-Free Open Roads, Chesapeake Barbara Skiffington President +1 757-546-3401 bbskiffington@q-free.com Q-Free ASA Roar Østbø CFO +47 932 45 175 roar.ostbo@q-free.com

Earlier release of Interim Report for January - June 2016

Zinzino hereby announces that the company will present the publication of the interim report for the period of January - June 2016, Friday the 26th of August at 13:00.        For more information, please contact: Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00 For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579 Certified Adviser: Erik Penser Bank www.zinzino.se The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 25, 2016.     Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

Continued strong growth and improved EBIT margin

· Net sales increased 21% to MSEK 159.1 (131.6). · EBIT rose 33% to MSEK 18.5 (13.9). · EBIT margin amounted to 11.6% (10.6). · Net income was MSEK 15.4 (9.7). · Earnings per share amounted to MSEK 1.54 (0.97). Stefan Jonsson, President and CEO:GARO performed strongly in many respects. The Group’s net sales increased 21% in the second quarter with sustained strong growth in Sweden and Other markets. The EBIT margin improved, thus contributing to a 33% increase in EBIT, and was mainly the result of volume growth combined with stable expenses, generating economies of scale.Net sales for GARO Sweden rose 17%, with significant increases in all product areas. The construction market remained strong with backlog demand for new apartments and single family homes. With GARO’s broad product range, this trend benefits our product areas of Electrical distribution products, Project business and Temporary electric installations. It is also gratifying to see that EV charging continues to grow strongly.Net sales for GARO Other markets rose 28%, with a strong increase primarily in EV charging in Norway, where we consolidated our leading position. Temporary electric installations also reported a satisfactory trend and it was gratifying that this product area performed so well in Finland. In Ireland, Electrical distribution products continued to follow the strong performance of the construction market.Gnosjö, 26 August, 2016  For more information, please contact:Stefan Jonsson, President and CEO: +46 70 588 66 73Lars Kvarnsund, CFO: +46 070 516 59 98Patrik Linzenbold, IR Director: +46 708 25 26 30  This information is such information that GARO aktiebolag is obligated to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was published by the abovementioned contact persons on August 26, 2016, at 7:30 a.m. GARO develops, manufactures and supplies innovative products and systems for the electrical installations industry under its own brand. The company has operations in Sweden, Norway, Finland, Ireland and Poland and the Group is organized in two business segments GARO Sweden and GARO Other markets. GARO has a broad product assortment and is a market leader within several product areas. The Group has sales of about MSEK 600 and has approximately 260 employees. Its head office is located in Gnosjö.The business concept is “with simplicity and design, GARO provides the smartest and most profitable solutions – fitted into systems.” 

CXENSE ASA ANNOUNCES SECOND QUARTER RESULTS - Q2 2016

OSLO, NORWAY - AUGUST 26, 2016 - CXENSE ASA TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER, WHICH ENDED JUNE 30, 2016.Highlights:- Q2 2016 revenues of USD 6.3 million, up 79% vs. Q2 2015, and New Annualized Recurring Revenue (ARR) closed in Q2 2016 of USD 2.6 million – 59% above the average of the last three quarters. - Strong new customer wins such as Aller Media AS and Japanese fashion retailer Nissen Co. Ltd, and significant upsell to existing client The Wall Street Journal. - Q2 2016 lost ARR (churn) was USD 1.4 million, due to higher than expected churn on legacy Maxifier software. Churn is expected to normalize in the following quarters. - Q2 2016 EBITDA of USD -1.3 million, a significant improvement from USD -3.1 million in Q2 2015. - Three new leading investors, Aker ASA, Charles Street International and Ferd AS, invested USD 19 million in new equity, enabling Cxense to faster pursue organic and acquired growth. - Accelerated sales growth is expected to move the EBITDA break-even point beyond 2016. - Cxense transferred to the Oslo Børs’ main list from Oslo Axess on 12 August 2016. “Cxense experiences increasing demand for its leading personalization and data management software and we successfully signed new customers and increased our engagement with existing ones in Q2 2016. Churn affecting ad solutions was disappointing, but is expected to move down in coming quarters. We have successfully strengthened our financial position, shareholder base and investor reach by raising new equity and listing on the Oslo Børs. We are now in position to invest in growth and take Cxense to the next level.”, says Ståle Bjørnstad, CEO of Cxense ASA The Q2 2016 report and presentation are attached to this notice. Cxense ASA is presenting its Q2 2016 results on Friday August 26, 2016, at 08:30 am CET. The presentation will take place at the Felix Conference Center, Bryggetorget 3,Oslo, Norway.  A live webcast will be available at:http://webtv.hegnar.no/presentation.php?webcastId=36208086  About CxenseCxense (pronounced "see-sense") enables the world's leading media, e-commerce and consumer brands to take control of their audience data to deliver more engaging and personalized user experiences. Businesses using Cxense's advanced real-time analytics, data management (DMP), advertising, search and personalization technology gain more engaged users, increased digital revenue and higher sales conversions. Cxense is headquartered in  Oslo, Norway, with offices worldwide.  Customers include the Wall Street Journal, USA Today (Gannett), Grupo Clarin, El Pais, Bonnier, Naspers, Ebay, The Golf Channel, PGA, NBA, NFL, ABC News, FOX Sports, Singapore Press Holdings, South China Morning Post, AEON, DMM, Rakuten and many more. For more information: www.cxense.com, Twitter: @Cxense. Cxense is listed on the Oslo Stock Exchange with the ticker 'CXENSE.'Investor Relations Contact:Jørgen Loeng, Chief Financial OfficerEmail: jorgen.loeng@cxense.comMobile: +47 906 60 062

Stefan Backman appointed Group General Counsel and new member of Tele2 AB’s Leadership Team

Stefan Backman replaces Caroline Fellenius-Omnell, who will assume the position of Executive Vice President Group General Counsel at Skanska Group. Stefan has a long and extensive background in telecoms, with experience from both legal and regulatory fields. He joined Tele2 in 2007 and has been pivotal in Tele2 Sweden's growth, particularly with respect to corporate development, governmental relations, regulatory affairs, corporate governance and most recently in the leadership of the network JVs. Stefan has a degree in Law from the University of Uppsala. Before being appointed to Group General Counsel, Stefan held the position of Head of Legal, Regulatory & Network at Tele2 Sweden. Allison Kirkby, President and CEO of Tele2 AB, comments: ”Stefan will contribute immediately and brings extensive commercial and legal experience from his years within Tele2, and from his professional training. I am extremely proud to be able to promote such a great individual from within our Tele2 talent pool, proving again Tele2's bench strength. Caroline has done a great job heading up our Group Legal and Regulatory team during a period of significant change, and I wish her every success in her new role.” Stefan Backman, incoming EVP Group General Counsel at Tele2 AB, comments: ”I am thrilled to accept this position and look forward to stepping up to the Group Leadership team, and supporting Tele2 as it pursues its responsible challenger strategy.” Caroline Fellenius-Omnell, resigning Group General Counsel at Tele2 AB, comments: “I have had a fantastic time at Tele2 and I want to thank all my colleagues for their dedication and hard work during these years. I am now looking forward to pursuing my new role at Skanska Group.” For more information, please contact:Viktor Wallström, Communications Director, Tele2 AB, Phone: +46 703 63 53 27Louise Tjeder, Head of Investor Relations, Tele2 AB, Phone: +46 704 26 46 52 This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the Director of Communications set out above, at 08:00am CEST on August 26, 2016. TELE2 IS ONE OF EUROPE'S FASTEST GROWING TELECOM OPERATORS, ALWAYS PROVIDING CUSTOMERS WITH WHAT THEY NEED FOR LESS. We have 16 million customers in 9 countries. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2015, we had net sales of SEK 27 billion and reported an operating profit (EBITDA) of SEK 5.8 billion. For definitions of measures, please see the last page of the Annual report 2015.

Bravida strengthens operations in Småland by acquiring OCM Vent

– This acquisition marks our return on the HVAC market in Småland, but it will also further strengthen our HVAC operations in Gothenburg, says Anders Ahlquist, Division Manager, Bravida Division South. The main part of OCM Vent’s operations is HVAC installation contracts, but there are also a great deal of service assignments. Among the customers are industries, retailers, private property owners and building companies. – The firm has had a strong growth lately and we felt that the next step for continued development was to enter a larger organisation. We have built our operations on long-term customer relationships. To us, it was important to sell to a company that shares our values, says Ola Knutsson, CEO of OCM. Åke Forsberg, Regional Manager for Bravida in Region Jönköping, is looking forward to supplementing Bravida’s offering in the area. – Finally! We have been without HVAC operations in Småland for some years now, and it feels great to be able to offer the complete set again – electrics, heating and plumbing and HVAC. For us, this acquisition will be the hub of continued development of our HVAC offering in our region, says Åke Forsberg. Bravida takes over the operations on 1 October 2016. For further information, please contact:Anders Ahlquist, Head of Division, Bravida Division South. Phone: +46 31-709 52 58Ola Knutsson, CEO, OCM Vent. Phone: +46 768-314 100Åke Forsberg, Regional Manager, Region Jönköping. Phone: +46 705-56 80 40Anders Bådholm, Regional Manager, Region Göteborg. Phone: +46 31-709 52 26

New Study: Swedish Nevisense can reduce follow-up visits by half for difficult-to-diagnose lesions in melanoma detection

Malignant melanoma is often difficult to detect, and early detection is of crucial importance. Lesions suspected of being malignant melanoma, but which cannot be clearly determined during the initial examination, are followed up in many cases with the help of what is known as short term digital dermoscopy imaging (SDDI), which means that the lesion is photographed and compared over time.  The use of SDDI is increasing – especially in difficult-to-diagnose cases – but it is resource-intensive and can take three months or more for a final diagnosis. In addition, it can be challenging to get patients to return for follow-up visits. In the new Australian study, conducted by Dr Lilian Rocha, Associate Prof. Pascale Guitera, Prof. Scott W. Menzies et. al. at the Melanoma Institute of Australia and Royal Prince Alfred Hospital in Sydney, SDDI was combined with Nevisense’s  electrical impedance spectroscopy (EIS) measurement with the following results: · 19% of all examined lesions showed a Nevisense EIS value of seven or more and were surgically removed immediately. 83.1% of the malignant melanoma in the study was discovered by Nevisense three months earlier than what SDDI would have allowed. · 28% showed a Nevisense EIS value of three or less, which would have made the need for a patient follow-up visit unnecessary. · The combination of SDDI and Nevisense detected 100% of all malignant melanoma in the study. In total, the use of Nevisense showed the potential to reduce the number of cases that needed to undergo SDDI by 47%. This could simplify diagnostics and lead to significant cost savings for health care while shortening patients’ waiting time for a diagnosis.  “The cases in the study involve difficult-to-diagnose lesions, and the current diagnostic process is time consuming for both clinicians and patients. This study result is very important because it shows the potential for Nevisense to improve the process - saving both time and resources in the healthcare sector” says Simon Grant, CEO at SciBase. For more information, please contact:Simon Grant, CEOPhone: +46 72 887 43 99Email: simon.grant@scibase.com This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CET on August 26, 2016. About Skin CancerSkin cancer is one of the most common cancers in the world, accounting for nearly half of all cancers. It has been estimated that nearly half of all Americans who live to the age of 65 will develop skin cancer at least once. Malignant melanoma is the most fatal form of skin cancer causing the majority (75%) of deaths related to skin cancer. Worldwide, doctors diagnose about 230,000 new cases of melanoma yearly. About SciBase and NevisenseSciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed a unique point-of-care device for the accurate detection of malignant melanoma. Its product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase was founded by Stig Ollmar, Associate Professor at The Karolinska Institute in Stockholm, Sweden. Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. Nevisense is CE marked in Europe, has TGA approval in Australia, and is awaiting FDA clearance in the United States. Nevisense is based on a method called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and thereby detect malignancies. SciBase is listed on Nasdaq First North (“SCIB”). Avanza is the certified advisor. Further information is available on www.scibase.com. 

Håkan Kirstein appointed as Eltel’s new CEO

Håkan Kirstein is currently a member of the Board of Directors at Eltel AB, which he joined in May 2016. He started his career in the retail business at Statoil and progressed to being CEO of Statoil Hydro Sweden AB. He spent 15 years at Statoil. Following the period at Statoil, Mr Kirstein held the position as CEO of Niscayah Group AB, a market leader in the technical security services and at that time listed on Nasdaq Stockholm. Under his leadership the company underwent a major transformation programme resulting in a significant profitability improvement. Prior to joining Eltel’s board, Håkan had an interim assignment as CEO of Imtech Nordic AB, a leading installation company in electrical engineering, heating and sanitation and HVAC technology. Eltel’s chairman of the Board of Directors Gérard Mohr comments: "Håkan Kirstein has a solid track record in the management of service business with high customer oriented focus and proven leadership skills in decentralised and multi-site companies, which fits well with The Eltel Way. He is also experienced in operations where excellence in project management is key. In addition, the Board was impressed by his strategic strength during his involvement in Eltel’s strategy review process in the first half of this year. I am confident that Håkan has excellent prerequisites to be successful in leading the future development of Eltel.” Håkan Kirstein comments: "I am honoured to have been appointed the CEO of Eltel. It is a privilege to be part of a company fiercely committed to delivering high quality service and solutions to our customers. I genuinely look forward to become part of the Eltel team”. As of 19 September Mr Kirstein will leave his position as member of the Board of Eltel and Mr Kirstein’s board position will currently not be replaced by a new member. Eltel’s Board of Directors and Axel Hjärne have agreed that Axel Hjärne will stay on in his position as CEO until 18 September 2016. “Under Axel Hjärne’s outstanding leadership, and thanks to his vision and his shaping of “The Eltel Way”, Eltel has grown to rank among the European leaders in the Infranet industry. On behalf of the whole Board, I thank Axel for his great contribution", says Gérard Mohr. For further information:Ingela UlfvesVP – IR and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com   This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 12.00 CET on August 26, 2016. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Interim Report for 1st January - 30th June 2016 Zinzino AB

” In July Zinzino launched their business in 19 new countries in Europe. This means that including the EU countries we are present in 33 countries in total in the world. That provides us a potential market with close to 1 billion people. During the second quarter we have launched new products and invested in a future in which we have a strong believe in. We will hold on to our ambitious goal to grow at least 20 percent in the coming 3 years and improve results every year. ” Dag Bergheim Pettersen, vd, Zinzino AB  SECOND QUARTER 2016 (COMPARED TO SAME TIME PERIOD LAST YEAR, 2015) · Total revenues amounted to SEK 109.1 (112.2) million which corresponds to a sales decline of 3% (+ 41%).  · The product segment Health increased by 4% to SEK 74.5 (71.6) million, which represented 68% (64%) of the total revenue for the quarter. The product segment Coffee amounted to SEK 15.3 (20.9) million which represented 14% (18%) of total revenue and a sales decline of 27%. Faun Pharma and other revenues amounted to SEK 19.2 (19.7) million representing the remaining 18% (18%) of total revenue.  · Gross profit amounted to SEK 35.8 (33.8) million and the gross profit margin amounted to 32.8% (30.1%).  · EBITDA amounted to SEK 4.6 (7.8) million and the operating margin before depreciation and amortisation to 4.2% (6.9%).  · Depreciation and amortisation amounted to SEK 2.2 (2.2) million, of which SEK 1.2 (1.4) million was attributable to depreciation of goodwill.  · Operating profit amounted to SEK 2.3 (5.6) million and the operating margin was 2.1% (5.0%).  · Profit before tax amounted to SEK 2.3 (5.2) million.  · Net earnings per share after tax (fully diluted) amounted to SEK 0.03 (0.12)  · The Annual Meeting of Shareholders adopted a dividend of SEK 0.25 (0.25) per share and in total distributed SEK 7.8 (7.7) million to shareholders.  CUMULATIVE JANUARI - JUNE 2016 (COMPARED TO SAME TIME PERIOD LAST YEAR, 2015) · Total revenues amounted to SEK 221.7 (221.2) million which corresponds to a sales increase of 0% (+43%).  · Zinzino Health increased by 10% to SEK 151.1 (137.6) million, which represented 68% (62%) of total revenue. Zinzino Coffee amounted to SEK 30.8 (42.4), which represented 14% (19%) of total revenue and a revenue decline of 27%. Faun Pharma and other revenues amounted to SEK 39.8 (41.2) million which represented the remaining 18% (19%) of total revenue.  · Gross profit amounted to SEK 76.8 (70.6) million and the gross profit margin amounted to 34.7% (31.9%).  · EBITDA amounted to SEK 12.8 (16.7) million and the operating margin before depreciation and amortisation to 5.8% (7.5%).  · Depreciation and amortisation amounted to SEK 4.5 (4.2) million, of which SEK 2.5 (3.0) million was attributable to depreciation of goodwill.  · Operating profit amounted to SEK 8.3 (12.5) million and the operating margin was 3.7% (5.6%).  · Profit before tax amounted to SEK 8.0 (11.7) million.  · Profit after tax amounted to SEK 5.2 (9.3) million.  · Net earnings per share after tax (full dilution) amounted to SEK 0.15 (0.28)  · Liquid assets amounted at the report date to SEK 24.0 (38.6) million.  SIGNIFICANT EVENTS DURING AND AFTER THE SECOND QUARTER OF 2016 · Through a new export initiative in the Swedish subsidiary Zinzino Sverige AB, Zinzino in early July commenced sales in the remaining, previously non-established markets in the EU such as Great Britain and Spain. The establishment model is simple and rapidly expansible with increased volumes. It is also very cost-effective to implement. If the investment turns out well it may generate substantial revenues for the company in the years ahead.  · Towards the end of the second quarter, Zinzino launched an entirely new product in Zinzino Health – BalanceOil AquaX. This is a further development of Zinzino’s BalanceOil to which has been added a unique emulsifying substance, Aquacelle. With BalanceOil AquaX the Omega-6/Omega-3 concept is taken to a whole new level.  · The product was developed through the Zinzino’s research company BioActive Foods together with the production unit Faun Pharma. This has led to the product development having been very fast and cost-effective.  · The Annual Meeting of Shareholders adopted a dividend to the shareholders. The Annual Meeting of Shareholders decided dividend to the shareholders of SEK 0.25 per share, which resulted in a total of SEK 7.8 million being distributed to the shareholders for the previous fiscal year. The current Board of Directors was re-elected for an additional year. · The subsidiary Faun Pharma AS signed a supply agreement with ProteinfabrikkenZinzino’s production plant Faun Pharma AS, during the second quarter, signed an important agreement with the key Norwegian customer Proteinfabrikken , this means an increase of Faun’s production by 500-600 tonnes per year. The agreement was signed for three years with an expected total value of more than NOK 30 million in increased sales during the period. Production was started during the summer and is estimated to amount to fully NOK 20 million for the rest of 2016, substantially more than had been expected.  · Internal efficiency improvements cut costs and reduced delivery timesDuring the quarter Zinzino has done further work to increase the efficiency of its operations. For this reason Zinzino is changing its collaboration partner as relates to billing, reminders and collections. This, combined with further development of the business system will result in cost savings of about SEK 1 million per year.  · Delivery of Zinzino Skin Serum - a new segment in Zinzino’s product range. Zinzino Skin Serum is the first product in the new product segment Skin Care and will be launched initially only on the American market. Launch on other markets is expected to happen in the autumn.  · Zinzino Skin Serum is developed by the company’s own researchers and reduces wrinkles and fine lines which are commonly associated with aging.  COMMENT BY DAG BERGHEIM PETTERSEN, CEO: We expand our business activity to the complete EU areaIn July Zinzino launched their business in 19 new countries in Europe. This means that including the EU countries we are present in 33 countries in total in the world. That provides us a potential market with close to 1 billion people. During the second quarter we have launched new products and invested in a future in which we have a strong believe in. We will hold on to our ambitious goal to grow at least 20 per- cent in the coming 3 years and improve results every year.  Second quarterDuring the second quarter we have fulfilled different strategic projects and investments. We have reached a big milestone in launching our business in 19 new markets in the EU. We launched a new future-oriented web shop with a new design. Within the segment Health we have launched a new product – AquaX – a BalanceOil that can be mixed with water. We launched new price structures and put more time and resources in design, layout and marketing. All these improvements are important for increasing the strength of our brand and create long term growth. By doing the investments necessary we feel that we have put a foundation to come closer to our goal in the coming year.  We are in line with the budget for this year and are relatively satisfied with the quarter although we still have not reached growth in comparison with the last year.Within Health we had a growth of 4 percent during the quarter but within the Coffee a decrease of 27 percent. We have bad margins on the coffee and therefor have to budget a decreasing on coffee with continuous higher focus on products within Health that have a bigger margin. We believe in a growth in the coming 6 months and have focus on improving the margins.  We improved our gross margins up till 32,8 percent, which is 2,7 percent better than as to the second quarter of 2015. Better margins proves that we are doing the right thing when we choose to invest in our business, open markets and continue to develop our own products and focus on people in Zinzino.  New IT-systemAs communicated before, during the last 12 months we have done huge investments in a new IT-system that can handle our growth and the geographic expansion that we planned. This is also an IT-system that can support us in our ambitious goal to have 1 million customers in 2020 and decrease costs for the next coming years. We faced challenges implementing the system which delayed our growth. We feel secure now with our IT-system and see that workflow is more effective, better and simple – that is something that makes us optimistic for the coming years.  Expansion planAs said before, we picked up the pace of our geographic expansion and opened 19 whole new markets. The new markets started up in an effective way and now we are active in 33 countries with almost 1 billion people. Wewill use the next 2 years to work in this market and at the same time planning the next step. After 4 years of hard work with market approach we see now that USA starts to give results. I believe that USA will be our biggest market within 2-4 years and will be leading for our company. USA is the world’s biggest Direct Selling market and we are appealing to partners because we have business model that is very customer focused.Germany established in the first quarter and is the biggest Direct Selling market in Europe. This is a powerful purchasing market, with the focus on health, we have of course high expectations for this market and we already see positive results of being present in the market.  Product developmentThe last 18 months we have actively worked on our product development and thanks to that we could launch our new products. Now we pick up the pace even more and we will launch several strong product concepts during 2016. I see product development one of the deciding factors for success for us and that is why I am proud over the fact that we, thanks to our own research and factory, we can always be one step ahead. New products make us an appealing company for our customers and distributors. With pleasure I can announce that we launched self-developed Skin Serum and even BalanceOil AquaX that we expect will bring us a lot of new customers and attract new partners. Skin Serum has an enormous big market potential and I believe this is going to be a big segment for us in the next coming years. BalanceOil AquaX will be a key product in our biggest product segment Health.  Ambitious GoalWe still have a huge believe in our ambitious goal to have a growth of at least 20 percent in the next three years and improving the results every year. We have a vision that we can inspire a change in life for our customers and partners. We will do this by being the most customer friendly Direct Selling company in the world. To confirm this we even communicated earlier that we will do this by having a million customers by the year 2020.We aspire to inspire!  Dag Bergheim Pettersen, vd, Zinzino AB  For a full report, please see the attached PDF.  INFORMATION ABOUT THE COMPANY: Zinzino was founded under the name Zinzino Holding in autumn 2007. In 2009, the company acquired 93% of the equity and 97% of the votes in Zinzino Nordic AB, partly by means of a non-cash issue and partly by means of a private placement. Zinzino Nordic is a sales company that uses independent distributors to market and sell products for commission via so-called direct sales.  NEXT REPORT: Interim report Q3 2016 will be published on 15 November 2016  For more information, please contact:Dag Bergheim Pettersen, CEO of Zinzino, Tel. no.: +47(0) 93 22 57 00For free to publish pictures, please contact: Anders Ekhammar, Tel. +46 (0) 707 462 579Certified Adviser: Erik Penser Bankwww.zinzino.se  The information presented here is such that Zinzino AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on August 26, 2016.    Zinzino AB (publ), which is listed on OMX First North, is a direct sales company focussing on health products. The company markets and retails products within two product lines: Zinzino Health, which focuses on long-term health and accounts for approx. 70 percent of sales, and Zinzino Coffee, which sells espresso machines and accessories. Zinzino has a market presence across the EU, Norway and Iceland, as well as in the USA and Canada. Zinzino offers eco-friendly products with a focus on quality, health and a sense of everyday luxury. The company’s values are characterised by high quality, proximity to customers and active product development. Zinzino owns the Norwegian knowledge company BioActive Foods AS and the research and production unit Faun Pharma AS, which produces all of Zinzino Health’s products and all protein products for Proteinfabrikken. Since 2005, Zinzino has been a general agent for the French Belgian coffee house Rombouts & Malongo. Zinzino forecasts a turnover of SEK 500 million for 2016. The Group has a head office in Gothenburg, a factory in Oslo, and offices in Helsinki, Oslo, Riga and Jupiter, Florida, and employs approximately 100 people.

ESS Data Management and Software Centre Opens in Copenhagen

"It makes me extremely proud to be the Minister for Higher Education and Science, when I see this amazing international knowledge hub -  ESS’ Data Management and Software Centre - being built in Copenhagen," says Ulla  Tørnæs. "It also makes me proud as a European to see ESS being built together, across borders, in Europe."  The new European research facility is expected to be the world's leading research facility using neutrons and is one of the highest priority research infrastructure projects in Europe. ESS is being built in Lund, Sweden, but will store and process the data it produces at DMSC in Denmark.   The data centre's new offices are located in the Copenhagen Bio Science building, on the north campus of the University of Copenhagen. During the current construction phase the DMSC staff consists of 22 employees developing software and hardware for the control, analysis, and visualization of the experiments to be carried out at ESS. They are working in collaboration with partners at universities and research laboratories all over Europe. When ESS goes into operations the data centre expects to have 60-70 employees. "The DMSC will provide the analysis and modelling software that will help the users of ESS turn data into scientific results and innovation,” says Mark Hagen, Head of DMSC and an experienced neutron scientist who has worked at most of the world's other leading neutron sources. "We are already very active in providing data analysis software for neutron scattering, collaborating on projects with our partners in the UK, France, Germany, USA and, of course, Denmark." The ESS user programme begins and opens for scientifc research in 2023. When that happens, it is expected to produce 3-5 petabytes (PB) of data per year, rising to 7-11 PB over the following years. The data will be transferred between ESS and DMSC through a dedicated fibre connection over the Oresund. "The DMSC in Copenhagen confirms the important role of Denmark as a host country for ESS," says Andreas Schreyer, ESS Director for Science. "The DMSC is a vital part of ESS which will provide new and unprecedented possibilities for the researchers to generate novel scientific results from the data generated in the experiments at ESS." ESS will be up to a 100 times brighter than any similar research facility and will enable scientists an unprecedented capability to probe matter with neutrons on atomic and molecular level. The research at ESS is expected to lead to many discoveries in scientific fields such as life science, energy and new materials.